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Abstract

Pitstick,A Lee. M.S., Department of Biological Sciences, Wright State University, 2011.
Nuclear Reorganization and Gene Expression During Muscle Cell Differentiation.

Cellular differentiation is a process regulated by environmental, intracellular and
intercellular factors. Myogenesis is a differentiation program in mammalian myotome
cells in which Pax3 activates myogenic transcription factors to convert myotome cells to
committed myoblasts. Myoblasts differentiate to become fully differentiated, multinucleated myotubes (Tajbakhsh et al., 1997). C2C12 cells are a model system for
myogenesis. We noted that Bcl2-associated transcription factor (Btf) is upregulated
during myogenesis. We observed that C2C12 nuclei reorganize during myogenesis. We
observed that myoblast nuclei have approximately 5-10 small nucleoli, while nuclei in
myotubes have fewer and larger nucleoli. Nucleolar reorganization occurs independently
of multinucleation. Also, the reorganization is not a result of serum withdrawal, as other
cell lines fail to show reorganization when grown in low serum conditions.
Immunofluorescent data indicates nuclear speckles reorganize during myogenesis. Our
results indicate that a large-scale reorganization of nucleoli and nuclear speckles occurs
during myogenesis.
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Chapter One: Background and Significance
1.1 Nuclear Domains
The cell nucleus orchestrates numerous processes including DNA replication, DNA
repair and recombination, ribosomal subunit assembly, nucleocytoplasmic and
ribonucleoprotein trafficking, and pre-mRNA processing (Lamond and Earnshaw, 1998).
These functions are often focused around distinct non-membrane bound organelles that
include paraspeckles, nucleoli, perinucleolar compartments, Cajal bodies, Gems,
promyelocytic leukemia (PML) bodies, and nuclear speckles (Spector, D.L., 2001;
Lamond and Spector, 2003). The structural integrity and/or biogenesis of these
organelles can often be attributed to sequence motifs found within the proteins that
localize to these organelles (Taddei et al., 2004). These motifs mediate protein-protein
and protein-nucleic acid interactions that result in self-assembly of these organelles
(Taddei et al., 2004). For example, immunofluorescence studies using monoclonal
antibodies localized the protein p120 to the nucleolus. These studies used site-directed
mutagenesis to identify an arginine-rich domain that overlapped with the protein‟s
nucleolar localization signal that was similar to that of other rRNA-binding proteins
(Freeman et al., 1988; Gustafson et al., 1998). This data suggested that the nucleolus
was capable of self-assembly and did not require an underlying scaffold structure
(Gustafson et al., 1998). Nuclear speckles are also enriched with proteins whose
sequence motifs are responsible for targeting them to nuclear speckles. Caceres and
colleagues transiently overexpressed several cDNAs for epitope-tagged SR proteins
coding for either the wild type protein or a deletion mutant construct and then studied the
1

cellular distribution of the tagged proteins (Caceres et al., 1997). This study revealed an
arginine-serine rich (RS) domain within several SR pre-mRNA splicing factors that was
necessary for targeting these proteins to nuclear speckles (Caceres et al., 1997). It is
possible that additional mechanisms also support the organization of nuclear bodies.
siRNA depletion of nuclear speckle protein Son showed a change in nuclear speckle
morphology from a solid sphere to a “donut” shaped morphology suggesting Son may
lend structural integrity to nuclear speckles and possibly serve as a protein scaffold for
nuclear speckles (Sharma et al., 2010). In addition, a growing number of noncoding
RNAs are involved in organization of nuclear bodies or their residential proteins. MALAT1 is needed for proper distribution of splicing factors in nuclear speckles (Tripathy et al.,
2010). Men ε and Men β are required for the integrity of nuclear paraspeckles (Sunwoo
et al., 2008).

1.2 The Nucleolus
Organelles and other structures within interphase nuclei exhibit a non-random
spatial organization in which each structure occupies a distinct and characteristic region
or domain. The nucleolus is the most dominant function-based compartment within the
nucleus. The nucleolus is the site of RNA polyermase I-mediated rDNA transcription and
ribosomal subunit assembly (Taddei et al., 2004). The nucleolus is composed of three
main sections, the innermost fibrillar center (FC), the dense fibrillar component (DFC),
and the granular component (GC) (Taddei et al., 2004). Both the GC and DFC are
embedded in the GC (Sirri et al., 2008). The FC has active and inactive rDNA genes and
the DFC is where processing and assembly of rRNA takes place (Taddei et al., 2004).
Finally, the later stages of ribosomal maturation and assembly take place in the GC
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(Taddei et al., 2004). Nucleoli localize to tandem repeats of rDNA known as nucleolar
organizing regions (NORs) (Taddei et al., 2004). Localization studies of NORs using
immunofluorescence microscopy have showed that NORs associate with the nuclear
envelope (Trumtel et al., 2000). This localization has been shown to be RNA polymerase
I dependent because when rDNA is transcribed with RNA polymerase II the localization
of nucleoli shifts away from the nuclear envelope (Trumtel et al., 2000). This model was
tested by disrupting the formation of the RNA polymerase I complex and then using
immunofluorescence to study localization of nucleolar protein ssb1. Localization of
ssb1had shifted away from the periphery of the nuclear envelope to internal regions of
the nucleus (Oakes, 1998).
The nucleolus forms around tandem repeats of rDNA referred to as nucleolar
organizing regions (NOR‟s) (Schardin et al., 1985; Eils et al., 1996). The transassociation of rDNA and NORs begins in an asynchronous manner shortly after
telophase of mitosis (Savino et al., 2008). Using cells stably transfected with green
fluorescent protein (GFP) tagged fibrillarin and GFP-tagged Nop52, localization of
nucleolar proteins was tracked using live microscopy (Savino et al., 2008). Results of
this study revealed that in early telophase, fibrillarin was concentrated in both
prenucleolar bodies (PNBs) and NORs; whereas, PNBs enriched with Nop52 did not
appear until later (Savino et al., 2008). Furthermore, analysis of PNBs revealed that
nucleolar proteins are most likely progressively delivered to nucleoli in the form of large
complexes based on their appearance through electron microscopy (Savino et al.,
2008). Using a combination of immunofluorescence, electron microscopy, and in situ
hybridization to study localization of RNA polymerase I upstream binding factor (UBF),
nucleolin, fibrillarin, and pre-rRNAs throughout mitosis and the beginning of interphase
revealed the nucleolar assembly occurred independently of rDNA transcription and prior
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to chromosome decondensation (Dousset et al., 2000). Other non-random aspects of
nuclear organization have been seen with Cajal bodies. Cajal bodies are localized
predominantly in the nucleoplasm at the periphery of nucleoli and to a lesser extent
within nucleoli (Malatesta et al, 1994). Interestingly, Cajal bodies show dynamic
organization within cell nuclei. Time-lapse confocal microscopy revealed that Cajal
bodies are mobile structures that may actually pass through nucleoli (Boudonck et al.,
1999). Nuclear body dynamics has also been observed for PML bodies, a subclass of
which shows metabolic-energy-dependent movement through the nucleoplasm
(Muratani et al., 2001).

1.3 Nuclear Speckles
Nuclear speckles were first reported by Hewson Swift in 1959 and termed
interchromatic particles based on their appearance and localization as observed by
electron microscopy (Swift, 1959). In 1961, the term “speckles” was introduced by J.
Swanson Beck after he examined rat-liver sections which had been immunolabeled with
the serum from patients suffering from autoimmune disorders (Beck, 1961). The
connection between pre-mRNA splicing factors and speckles was first revealed when
immunolabeling studies showed that nuclear speckles have small nuclear
ribonucleoprotein (snRNP) splicing factors (Spector, et al., 1983). Nuclear speckles were
later shown to be the equivalent of the interchromatin granule clusters (IGCs) (reviewed
in Lamond and Spector, 2003.). IGCs vary in size and are irregularly shaped (Thiry,
1995). Nuclear speckles are located exclusively in the nucleus, contain little to no DNA
and are distinct from other splicing factor-containing structures in the nucleus such as
perichromatin fibrils, Cajal bodies, interchromatin granule-associated zones, and
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paraspeckles (Huang and Spector, 1997; Thiry, 1995; Fox et al., 2002). In situ
hybridization studies show that highly active genes and transcripts are associated with
the periphery of nuclear speckles and BrUTP labeling in permeabilized mammalian cells
showed that transcription also occurs within nuclear speckles (Wei et al., 1999; Xing et
al., 1995).
Nuclear speckles contain pre-mRNA splicing factors including snRNPs and SR
proteins (proteins with a region rich in arginine and serine residues) as observed by
immunolabeling of these proteins (Fu, 1995). Additionally, proteomic analysis of nuclear
speckles revealed that speckles contain the large subunit of RNA polymerase II (Saitoh
et al., 2004). Studies revealing the dynamic behavior of nuclear speckles have shown a
constant flux of splicing factors between nuclear speckles and the nucleoplasm, which
suggested that nuclear speckles serve as storage sites for pre-mRNA processing
machinery (Saitoh et al., 2004). Studies using live cell microscopy have documented the
recruitment of splicing factors from nuclear speckles to sites of active transcription;
furthermore, when pre-mRNA splicing is inhibited, speckles round up and become larger
and more defined (Misteli, et al., 1997; O‟Keefe, R.T., et al., 1994). Misteli et al. (1996)
reported that phosphorylation of the RS domain of SR proteins mediates splicing factor
recruitment to active transcription sites. Furthermore, the presence of a variety of
kinases and phosphotases within nuclear speckles supports this hypothesis (Mintz et al.,
1999). In addition to splicing factor phosphorylation, the carboxy terminus of the large
subunit of RNA polyermase II is also phosphorylated and required for targeting splicing
factors to sites of active transcription (Misteli and Spector, 1999). Removal of the
carboxy-terminus from the large subunit of RNA polyermase II inhibits both splicing
factor recruitment to the transcription site and pre-mRNA processing (Misteli and
Spector, 1999).

5

1.4 Cell Cycle Dynamics of Nuclear Domain Organization
When cells enter mitosis, nuclear domains completely disassemble, then assemble
in newly formed daughter nuclei, presumably using the above-described self-assembly
mechanisms. Although direct comparisons have not previously been made, it seems
reasonable that a similar assembly process to what has been observed for nucleoli in
post-mitotic daughter cells could be involved in nucleolar reorganization in response to
other biological cues. For part of my project, I wished to study nuclear reorganization
during muscle cell differentiation. This situation is likely similar to mitotic exit, since
differentiating muscle cells leave a proliferative state and become programmed toward a
less proliferative, specific cell type. In order to properly describe subtle changes in
nuclear organization as well as to put conclusions about my observations into context
with what is already known about nucleolar organization, it was important to consider
nuclear organization and dynamics of not only interphase cells but also cells undergoing
mitotic division. In other words, an understanding of post-mitotic nuclear organization
may lend insight to nuclear reorganization observed during muscle cell differentiation.
During mitosis, nucleoli disassemble and are no longer visible during prophase when
rDNA transcription is repressed (Sirri et al., 2008). Immunolabeling of rRNA processing
machinery with autoimmune sera collected from patients showed that at the beginning of
prophase, rRNA processing components do not stay associated with rDNA at the NORs
but become distributed over the surface of chromosomes (Hernandez-Verdunt et al.,
1993; Gautier et al., 1992). Kinetic studies of fluorescently tagged RNA polymerase I
subunit RPA39 and nucleolar protein fibrillarin revealed that these components
transiently dissociate from NORs during metaphase and return in anaphase (Leung et
al., 2004). Live cell microscopy with green fluorescent protein (GFP) tagged nucleolar
proteins fibrillarin and Nop52 revealed that components of the dense fibrillar center
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(DFC) and granular component (GC) portions of the nucleolus relocate to the
chromosome periphery and migrate with chromosomes during telophase (Savino et al.,
2001). These proteins then assemble at pre-nucleolar bodies (PNBs) located at the
chromosome surface followed by progressive delivery of nucleolar proteins to NORs
(Savino et al., 2001).
Also as part of my project, I wanted to document changes in nuclear organization of
nuclear bodies during muscle cell differentiation. Dynamics of nuclear bodies other than
nucleoli has been documented during mitosis. For example, immunofluorescence
microscopy using an anti-p80 coilin antibody revealed that Cajal bodies change in size
and number during mitosis (Andrade et al., 1993). Serum starvation studies in 3T3
mouse fibroblasts, revealed that cells which are not actively cycling only posses 0-1
Cajal bodies (Andrade et al., 1993). The number of Cajal bodies per cells is highest in
mid-to late G1. As the cells progress through S phase and G2, Cajal bodies decrease in
number and in size and eventually disappear in mitosis (Andrade et al., 1993; Andrade
et al., 1991). Paraspeckles remain intact throughout mitosis until the cell enters
telophase (Fox et al., 2002). Paraspeckles are RNA polyermase II transcriptiondependent bodies found adjacent to nuclear speckles during interphase. In early
telophase, when RNA polyermase II transcription is absent, paraspeckle proteins
redistribute and form a crescent shaped perinucleolar cap within the nucleolus (Fox et
al., 2002). As the cells exit mitosis and RNA polymerase II transcription resumes,
paraspeckles reform in the interchromatin space in close proximity to nuclear speckles
(Fox et al., 2002). Interestingly, the multiple endocrine neoplasia (Men1) locus shows
upregulation of two noncoding RNAs, Men ε and Men β, during differentiation of mouse
muscle cells (Sunwoo et al., 2008). Changes in nuclear organization of paraspeckles
correlate with upregulated expression of these noncoding RNAs, as foci containing these
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RNAs are enlarged and more numerous in differentiated myotubes than in myoblasts
(Sunwoo et al., 2008).
Nuclear speckles, just like paraspeckles, undergo reorganization during mitosis at
the onset of nuclear envelope break down (NEBD). At this time, proteins associated with
nuclear speckles become diffusely distributed throughout the cytoplasm (Ferreira et al.,
1994; Spector et al., 1986). When the cells progress to metaphase, proteins from
nuclear speckles predominantly remain diffusely distributed in the cytoplasm. During
metaphase, these proteins start to accumulate in one to three small structures called
mitotic interchromatin granules (MIGs) that increase in size and number through
anaphase and early telophase (Ferreira et al., 1994; Leser et al., 1989; Prasanth et al.,
2003; Spector and Lammond, 2010). After mid-to late telophase, following reformation of
the nuclear envelope and nuclear lamina, localization of pre-mRNA splicing factors to
MIGs decreases as they enter newly formed daughter nuclei (Prasanth et al., 2003).

1.5 Myogenesis
Myogenesis is the progression of undifferentiated somite cells to fully differentiated,
multi-nucleated myotubes. All skeletal muscle arises from mesodermal precursor cells in
the somite (Molkentin and Olson, 1996). Somite cells themselves are created from the
segmentation of paraxial mesoderm; furthermore, the somite becomes
compartmentalized into separate cellular regions in response to signals from the
notochord and neural tube during embryogenesis (Christ and Ordahl, 1995). Once the
signals are received, the dorsal portion of the somite, also referred to as the
dermamyotome, will give rise to the dermis and skeletal muscle (Molkentin and Oson,
1996). Specifically, induction of myogenesis comes from the notochord and ventral half
8

of the neural tube. The myogenic signal consisting of Wnt and Shh signaling proteins is
soluble, it is essential for expression of basic helix-loop-helix (bHLH) myogenic
regulatory factors (MRFs) and it does not require cell-to-cell contact (Buffinger and
Stockdale, 1995). MRFs posses a conserved basic helix loop helix (bHLH) tertiary
structure and they all bind to similar sequences of DNA to activate muscle-specific
genes (Weintraub et al., 1991). The mode of action for MRFs entails heterodimerization
with E2A gene products followed by binding to the consensus sequence of the E Box
near the promoter region of muscle-specific genes (Molkentin and Olson, 1996). The E
box is a DNA sequence typically found upstream of the promoter of genes that is
recognized for binding of bHLH structural motif of MRFs in order to enhance
transcription (Chaudhary et al., 1999). In addition to promoting transcription of musclespecific genes, MRFs can physically interact with myocyte enhancer factors (MEFs) to
activate muscle-specific genes (Molkentin et al., 1995). MRFs have a very potent
regulatory effect capable of converting many non-muscle cell types into muscle in vitro
(Choi et al, 1990, Davis et al., 1987, Molkentin and Olsen, 1996).
Munsterberg and colleagues showed that Wnt 1, Wnt 3, and Wnt 4 cooperate with Sonic
Hedge Hog (Shh) to induce myogenesis in somites isolated in vitro (Munsterberg et al.,
1995; Molkentin and Olson, 1996). Wnt signaling is mediated by a β-catenin-TCF/LEFdependent canonical pathway which directly interacts with MyoD to enhance MyoD
binding to the E box in the promoters of muscle specific genes (Kim et al., 2008). Within
the lateral somite, these signals originate from the neural tube and notochord and induce
the Pax3 transcription factor that in turn activates expression of MRF family members
MyoD and Myf5 (Muntsberg and Lassar 1995; Weintraub et al., 1991). A schematic
representation of muscle cell differentiation induction can be found in Figure 1.1.
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Figure 1.1. Induction of muscle cell differentiation via Wnt and Shh. Signalling
proteins Wnt and Sonic hedge hog (Shh) originate from the ventral neural tube and
notochord, respectively, and induce differentiation through activation of MRF family
members Myf5 and MyoD (Stern et al., 1995). Adapted from Molkentin and Onson,
1998.
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Adapted fromMolkentin and Olson, 1996
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After Pax3 induces expression of MyoD in muscle precursor cells, MyoD-driven
activation of additional MRFs needed for differentiation is sequestered in proliferating
myoblasts through direct transcriptional repression and by blocking signaling pathways.
Within proliferating myoblasts, several proteins and cellular signaling pathways work to
suppress transcriptional activity of MRFs and myocyte enhancer factors (MEFs). The
Inhibitor of Differentiation (Id) protein negatively regulates MRFs to inhibit myogenesis;
specifically, Id will bind and sequester either MRFs or E2A proteins to prevent MRFs
from binding to the consensus sequence within the E box in the promoter region of
muscle specific genes (Benezra et al., 1990). Myostatin is another protein involved in
negatively regulating transcription of MRFs. Specifically, myostatin inhibits the synthesis
and activity of MyoD (McPherron et al., 1997; Amthor et al., 2004; Guttridge 2004).
Myostatin is a member of the transforming growth factor-β family and is unique in that it
negatively regulates both myogenesis and muscle cell proliferation in order to maintain
muscle homeostasis within an organism. Organisms null for myostatin show increased
muscle mass due to hypertrophy (McPherron et al., 1997).
Multiple other signaling pathways are involved in negatively regulating
myogenesis within proliferating myoblasts. The Janus kinase signal transducer and
activator of transcription (JAK-STAT) pathway is a very well characterized pathway that
is both required for myoblast proliferation and an important checkpoint to prevent
premature differentiation of myoblasts; furthermore, knockdown of the JAK1-STAT1STAT3 pathway induced premature differentiation of myoblasts through induction of
MyoD and MEF2 and downregulation of Id1 (Luguo et al., 2007; O‟Shea et al., 2002).
The Stau1 pathway is also involved in negative regulation of myogenesis (Yamaguchi et
al., 2008), as knockdown of Stau1 enhanced myogenesis. Cells depleted of
Stau1showed an increase in myogenin promoter activity, indicating that Stau1 may work
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to inhibit an event directly prior to activation of the myogenin promoter (Yamahuchi et al.,
2008). Stau1 also inhibits myogenesis through association with the UPF-1 protein, which
is a component of mRNA decay machinery that attacks MyoD mRNA (Yamaguchi et al.,
2008). Another signaling pathway, the notch pathway, inhibits myogenesis through
repression of MyoD (Buas and Kadesch 2010; Kopan et al., 1994). Ectopic expression of
notch inhibits differentiation of C2 myoblasts upon serum deprivation and stops the
conversion of 3T3 cells transfected with expression vectors driving Myf5 or MyoD
expression. Furthermore, evidence indicates that notch expression does not stop the
binding of E proteins to the E box-binding site within MyoD, but rather targets the bHLH
region of MyoD following heterodimerization (Kopan et al., 1994).
In order for myoblasts to differentiate, they must withdraw from the cell cycle
(Molkentin and Olson, 1996). Withdrawal from the cell cycle and subsequent
transcription of muscle-specific genes requires the removal or depletion of fibroblast
growth factors (FGFs) in the surrounding environment (Menko and Boettiger, 1987).
After FGFs are absent from the environment, several proteins associated with the cell
cycle and cell cycle progression is modified in terms of structure and/or expression
levels to promote cell cycle withdrawal and differentiation. For example, the
retinoblastoma (Rb) protein is phosphorylated in proliferating cells to sequester it and its
growth-inhibiting activity; however, when FGFs are depleted, the Rb protein is
dephosphorylated and becomes active (Molkentin and Olson, 1996; Weinberg, 1995).
Rb then sequesters the E2F family of transcription factors that directly activate the
expression of several genes required for cell proliferation (Weinberg 1995). MRFs are
suppressed in proliferating myoblasts, and forced expression of these proteins inhibits
cell cycle progression, suggesting that MRFs and proteins associated with cell cycle
progression modify each other‟s activities (Molkentin and Olson, 1996) as exemplified by
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the relationship between cyclin D1, Rb, Cdk inhibitor 21, and MRF proteins. In
proliferating myoblasts, cyclin D1 suppresses Rb and allows for progression of the cell
cycle, specifically at the G1-S transition. Furthermore, cyclin D1 inhibits MyoD-mediated
transcriptional activation of MRFs (Skapek et al., 1995; Molkentin and Olson, 1996).
After myoblasts receive the signal to differentiate, Cdk inhibitor p21 is upregulated and
suppresses cyclin D1 (Skapek et al., 1995). When cyclin D1 is inhibited, Rb and MyoD
are no longer sequestered and can inhibit cell cycle progression and allow activation of
MRFs respectively (Skapek et al., 1995; Guo et al., 1995). Figure 1.2 summarizes these
interactions.
When differentiation is induced and cell cycle progression is halted, expression of
muscle-specific genes is upregulated, further directing myoblasts along the
differentiation program. In addition to MyoD and Myf5, the MRF family of proteins
consists of Myogenin and Myf4, which also play crucial roles in ensuring terminal
differentiation of myoblasts (Weintraub et al., 1991). Following activation of the MRFs
myogenin and Myf4, myogenin is likely to cooperate with MyoD and Myf5 to activate
muscle contractile genes such as myosin heavy chain (MHC) (Lassar et al., 1991).
During differentiation, expression and activity of MRFs is positively regulated through a
number of proteins and pathways. For example, the half-lives of MyoD, myogenin, and
p21 mRNAs are extended during myogenesis (Myer et al., 1997; Kao et al., 1994).
Proteins HuR and NF90 both work to bind to the Au-rich element of the 3‟ untranslated
region (3‟ UTR) of muscle-specific transcripts to protect against degradation (Myer et al.,
1997; Kao et al., 1994). A protein called titin-cap (TCAP) positively regulates
myogenesis through interaction with myostatin. When TCAP is knocked down via RNA
interference, the expression of MyoD and myogenenin also decreases (Nicholas et al.,
2002). Another protein, numb, works to promote myogenesis through inhibition of the
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Figure 1.2. Interaction between MRFs and cell cycle progression-related proteins.
MRFs and proteins involved with cell cycle progression modify each other‟s activities. In
proliferating myoblasts cyclin D1 supresses Rb and MyoD-mediated transcriptional
activation of MRFs. In differentiating myoblasts, Cdk inhibitor p21 inhibits cyclin D1 and
Rb and MyoD-mediated transcription become active. Adapted from Molkentin and Olson,
1998.
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Adapted from Molkentin and Olson, 1996
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notch signaling pathway (Buas and Kadesch 2010). During endocytic trafficking, notch
can be sent to the early endosome for recycling in the cell or sent to the late endosome
for degredation. Overexpression of numb followed by surface biotinylation and trafficking
assays revealed that in the presence of numb, notch is preferentially sent to the late
endosome for degredation indicating that numb inhibits the notch signaling pathway
through endocytosis (McGill et al., 2009).
After myoblasts receive the signal to terminally differentiate, myoblasts will align into a
chain-like formation in preparation of fusion to become the multi-nucleated myotube
(Knudsen, 1985). Cellular fusion within myogenesis is actually divided into two stages;
the first consisits of myoblasts fusing with other myoblasts, and the second involves
myoblasts fusing to existing myotubes (Rochlin et al., 2010). The alignment process is
mediated by cellular membrane glycoproteins including several cadherins and cell
adhesion molecules (CAMs). Furthermore, this process requires that neighboring cells
participating in the fusion event are all myoblasts (Knudsen et al., 1990). In order for
myoblasts to become aligned, they must first migrate towards one another. The actin
cytoskeleton is crucial in facilitating migration of myoblasts. Myoblasts treated with
latrunculin A or cytochalasin D (that interfere with F-actin) exhibit hindered myoblast
migration (Coue et al., 1987; Dhawan and Helfman, 2004; Nowak et al., 2009;
Constantin et al., 1995; Sanger and Holtzer, 1972). Once myoblasts are aligned, cellular
membranes are dissolved and multiple myoblasts join together to form one
multinucleated myotube (Konigsberg, 1963; Mintz and Baker, 1967). Different proteins
are involved in myoblast-to-myoblast fusion than are involved in myoblast-to-myotube
fusion (Rochlin et al., 2010). Proteins including β1-integrin, VLA-4, VCAM, and caveolin3 are involved in myoblast-to-myoblast fusion (Schwander et al., 2003; Rosen et al.,
1992; Galbiati et al., 1999). The NAFTC2 pathway activated by calcium, calmodulin, and
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IL-4 cytokine is involved in regulating myoblast-to-myotube fusion (Rochlin et al., 2010).
In summary, there is a relatively clearly defined molecular pathway for muscle
cell differentiation and for regulation of gene expression during myogenesis. The
proteins involved in the molecular pathways leading to muscle cell differentiation provide
an excellent roadmap of cellular markers that can be used to understand how proteins
that have not previously been assigned any functions in muscle cells might participate in
muscle cell differentiation. Within this study, we used key proteins and morphological
states (namlely myogenin, myosin heavy chain (MHC), and mulitinucleation) to study
how Bcl-2- associated transcription factor (Btf) functions might possibly participate
muscle cell differentiation. Using a combination of immunofluorescence labeling of Btf as
well as myogenin and MHC and western blot analysis, we have studied the labeling and
relative expression levels of Btf throughout the differentiation time course using a C2C12
mouse myoblast cell line.
1.6 Nuclear Organization and Muscle Cell Differentiation
Cellular differentiation requires a vast shift in gene expression. Given that nuclear
structure is functionally related to gene expression, it stands to reason that a shift in
gene expression would lead to a shift in nuclear structure. Recent studies indicate that
genome architecture is dynamic and varies with the cell cycle and physiological state of
the cell (Ferguson and Ward, 1992; Vourch‟h et al., 1993; Nagase et al., 1996; Brero, et
al., 2005). During cellular differentiation, genes that have been previously silenced
through repressive conformations imposed by nucleosomes must be made accessible to
transcription factors (Cairns, 2009). Nucleosome-enforced repression can be overcome
by a combination of tissue-specific transcription factors and multi-subunit machineries
that remodel nucleosomes (Berkes and Tapscott, 2005). In the case of myogenesis,
MyoD and Myf5 must be able to bind the E box within the promoter regions of muscle18

specific bHLH genes such as myogenin and Myf4 (Berkes and Tapscott, 2005). A
combination of physical and functional interactions between bHLH proteins and
SWI/SNF chromatin remodeling complexes allow for the rearrangement of nucleosomes
to remodel the chromatin in way that favors transcriptional access of MyoD and Myf5 to
muscle-specific bHLH and MEF2 factors (de la Serna et al., 2001; Simone et al., 2004).
The SWItch/Sucrose NonFermentable (SWI/SNF) is an ATP-dependent chromatin
remodeling unit which consists several proteins that are products of the SNF and SWI
genes as well as two main catalytic subunits, Brg1 and Brm (de la Serna et al., 2001;
Simone et al., 2004; de la Serna et al., 2006). In addition to catalytic subunits, different
combinations of noncatalytic subunits including Brg1/Brm-associated factors (BAFs)
provide the SWI/SNF complex with molecular variability allowing the complex to
selectively interact with different tissue-specific transcription factors and other chromatinremodelling enzymes (Wu et al., 2009). The mechanism by which the SWI/SNF complex
remodels chromatin involves altering the position of nucleosomes along the DNA
through ATPase activity that works to destabilize DNA-histone interactions; however, the
exact change in structure is unknown (Pazin et al., 1997; Whitehouse et al., 1999). In
addition to general chromatin remodeling, Chaly and Munro studied localization of
centromeres during myogenesis in vitro using a L6E9 rat myoblast cell line (Chaly and
Munro, 1996). During myogenesis, centromeres relocated to the nuclear periphery;
furthermore, condensed chromatin was more prevalent at the myotube nuclear envelope
as observed by electron microscopy (Chaly and Munro, 1996). Regions of
heterochromatin also display a spatial clustering that is reliant on histone deacetylase
(HDAC) activity (Terranova et al., 2005). However, characterization of nuclear
organization of other nuclear domains during muscle differentiation is limited, and our
project aimed to observe changes in nucleoli and nuclear speckles relative to the
differentiation timeline in C2C12 cells.
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1.7 Bcl-2 Associated Transcription Factor
Several nuclear speckle proteins have recently gained attention due to unique
domain structure and/or suggested functions. One of the non-classical SR proteins
identified in a proteomic analysis of purified mouse nuclear speckles was Bcl-2
associated transcription factor (Btf) (Saitoh et al., 2004). Btf showed some colocalization
with splicing factors in nuclear speckles, and it has an RS domain; however, the RS
domain in Btf is located at the N-terminus rather than the C-terminus where it is typically
found in classical SR proteins (Saitoh et al., 2004; Mintz et al., 1999). Btf is a
transcription repressor that, when overexpressed, induces apoptosis through inhibition of
the anti-apoptotic Bcl-2 protein family (Kasof et al., 1999; Haraguchi et al., 2004).
Interestingly, Btf is expressed at high levels in skeletal muscle (Haraguchi et al., 2004;
Nagase et al., 1996). Previous evidence suggests that Btf may associate with emerin,
(Haraguchi et al., 2004; L. Ford and P. Bubulya, unpublished data), a 34kDa, 254-amino
acid, serine-rich inner nuclear envelope protein (Haraguchi et al., 2004; Fairley et al.,
1999).
Emerin is thought to possibly regulate mechanosensitive and stress-induced genes,
contributing to overall muscle maintenance and integrity (Fairley et al., 1999; Ostlund et
al., 1999). In addition to Btf, emerin binds to lamins A and C, lending structural integrity
to the cell according to the Structural Hypothesis (Salpingidou et al., 2007). The
Structural Hypothesis proposes that the network of emerin and lamins serve as the loadbearing center of the nuclear envelope, and that bridging complexes span the nuclear
envelope connecting the inner nuclear membrane with the actin cytoskeleton
(Hutchinson et al., 2002; Crisp et al., 2006). Muscle cells null for emerin undergo cell
death and eventual muscle wasting; furthermore, a number of emerin mutations have
been associated with Emery-Dreifuss Muscular Dystrophy (Broers et al., 2004,
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Salpinidou et al., 2007). Select mutations in emerin that have been associated with
EDMD occur within the region of emerin that associates with Btf (Salpinidou et al.,
2007). Although emerin with such naturally occurring mutations (for example, a serine to
phenylalanine substitution at residue 54 (S54F), a proline to histidine substitution at
residue 183 and a proline to threonine substitution at residue 183) demonstrated normal
levels and localization (Haraguchi et al., 2004), One might predict disrupted Btf-emerin
association, that could lead to altered function in muscle cells. Based on the supposed
interaction of Btf and emerin and Btf‟s putative role in EDMD, we wish to investigate a
possible role for Btf in muscle cells. However, because the behavior of nuclear speckles
and constituent proteins is poorly characterized during muscle cell differentiation, we set
out to build a timeline of these events in C2C12 mouse myoblasts.
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Chapter 2: Hypothesis and Experimental Amis
Emery-Dreifuss muscular dystrophy (EDMD) is an X-linked recessive disorder
causing progressive muscle wasting, cardiomyopathy, and a deformation of muscular
tissue in the elbows, Achilles tendon, ankles, and spine (Emery 1989). Sudden death
resulting from cardiac defects can be averted with early diagnosis and pacemaker
placement; however, there is no treatment for the accompanying muscle wasting (Ellis et
al. 1999). Most EDMD patients are null for the nuclear protein emerin resulting from
nonsense mediated decay (Haraguchi et al., 2004). Emerin is a 34kDa, 254 amino acid,
and serine rich, nuclear envelope protein; furthermore, emerin is predicted to be a type II
membrane protein possessing a transmembrane region (Haraguchi et al., 2004; Fairley
et al., 1999). Emerin is thought to possibly regulate mechanosensitive and stressinduced genes, contributing to overall muscle maintenance and integrity (Fairley et al.,
1999; Ostlund et al., 1999). A subset of EDMD patients demonstrate normal amounts
and localization of emerin at the inner nuclear membrane in contrast to most EDMD
patients whom produce no detectable emerin as observed by immunoblotting and
immunohistochemistry; furthermore, all of these mutations that produce seemingly
“normal” emerin occur within regions of emerin which associate with Btf (Haraguchi et
al., 2004; Fairley et al., 1999). This set of mutations includes a serine to phenylalanine
substitution at residue 54 (S54F), a proline to histidine substitution at residue 183 and a
proline to threonine substitution at residue 183 (Haraguchi et al., 2004).
Based on the supposed interaction of Btf and emerin as well as Btf‟s putative role
in EDMD, we investigated a possible role for Btf in muscle cells using a C2C12 mouse
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myoblast cell line. C2C12 differentiation in our hands reflected timing and gross
morphological changes seen previously (Konigsburg, 1963; Mintz and Baker, 1967;
Lassar et al., 1989). This is important because it allowed likewise comparison of our data
and data of other labs which have done work on muscle cell differentiation in C2C12
cells. Preliminary experiments revealed that Btf was upregulated during differentiation as
observed by immunoflourescence microscopy and immunoblotting (Figure 2.1)
(Theadore Hufford, Alok Sharma and Paula Bubulya, unpublished data). I performed
differentiation time course experiments in which I immunolabled Btf and muscle specific
proteins which validated observations made by an undergraduate honors student who
had only done the experiment once. I therefore hypothesized that increased expression
of Btf may be important for muscle cell differentiation. In order to test this hypothesis, I
designed experiments in which Btf was overexpressed and experiments in which Btf was
depleted. Given that Btf is upregulated during differentiation, I overexpressed Btf in
undifferentiated C2C12 cells to determine if overexpression of Btf could induce
differentiation or possibly expedite the differentiation time course as compared to C2C12
cells undergoing a normal differentiation time course induced by serum deprivation.
Controls were included to assert that transfection alone was not altering differentiation,
that transfected cells could indeed differentiate, and that timing of differentiation in
transfected samples which were either induced or not induced to differentiate matched
the timing of untransfected samples maintained in the same conditions. Given that Btf is
upregulated during differentiation, I also designed experiments to deplete Btf in C2C12
cells and induce differentiation to determine if C2C12 cells depleted of Btf could undergo
normal differentiation. siRNA was utilized for Btf depletion and differentiation via serum
deprivation was induced 24 hours following siRNA treatment. Cells treated with siRNA
buffer alone, siRNA oligs targeted against luciferase, as well as untransfected cells were
used as controls.
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Figure 2.1. Western blot analysis to detect expression of nuclear and muscle
specific proteins during differentiation of C2C12 myoblasts. WCNE was prepared
on each day of the differentiation time course. Equal total protein in each sample was
loaded onto SDS-PAGE and transferred to a nitrocellulose membrane for
immunoblotting. Upon stimulus to differentiate, expression of muscle-specific gene
myogenin was increased at Day 1 and MHC expression was increased at Day 2. Btf
expression is detectable at Day 1 and increases through Day 4 of the differentiation time
course. Nuclear speckle protein SF2/ASF also show increased in expression between
Day 0 and Day 1. Actin was used as an equal loading control. Western Blot was
performed by Alok Sharma.
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In addition to Btf upregulation during C2C12 differentiation, preliminary experiments
showed surprising nuclear reorganization. To investigate this further, I did differentiation
time course experiments in which I observed nuclear domains. My results substantiated
observations made by an undergraduate honors student who had only done the
experiment once. I therefore proposed that muscle cell differentiation as observed in
C2C12 cells resulted in reorganization of nuclear domains. To test this hypothesis, I
designed experiments to investigate nuclear speckle and nucleolar organization
throughout the differentiation process as well as experiments to assert that the observed
nuclear reorganization was not a result of serum starvation. To observe nuclear speckles
and nucleoli during the differentiation process, I performed differentiation time course
experiments in which I immunolabeled for nuclear speckle protein Son or nucleolar
protein fibrillarin as well as muscle specific proteins myogenin and MHC. I also
performed serum starvation experiments with HeLa and MEF cells to confirm that the
nuclear reorganization observed in differentiating C2C12 cells was not a result of serum
starvation or a muscle specific phenomenon. Throughout differentiation, both nuclear
speckles and nucleoli change in morphology from diffuse and less enriched bodies to
more punctuate and enriched bodies; therefore, I hypothesized that nuclear domains
most likely reorganize in one and/or two ways. One proposed method is that nuclear
domains fuse during differentiation and the other possibility is that some nuclear
domains recede while others enlarge (Figure 2.2). To test this hypothesis, I designed
experiments to image nucleoli in differentiating C2C12 cells live. I performed
experiments to optimize transfection of CFP-fibrillarin plasmid DNA via electroporation
and experiments to determine the optimal time for imaging to capture the change in
nucleolar morphology.
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Figure 2.2. Proposed model for nuclear reorganziation as observed in
differentation of C2C12 myoblasts. Two modes of action were proposed to describe
the change in nuclear organization. The first model suggests that multiple domains fuse
together over time, while the second models suggests that certain nuclear domains
become larger while others recede over time.
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I hypothesized that Btf is important for muscle cell differentiation and muscle cell
differentiation results in nuclear reorganization. My specific experimental aims were as
follows:
Aim I.
Investigate effects of Btf overexpression and depletion on C2C12
differentiation.

Aim II.
Characterize the nuclear reorganization events that occur during muscle
differentiation and image nucleolar reorganization events in live cells.
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Chapter Three: Materials and Experimental Methods
3.1 Cell Culture
C2C12 cells (ATCC) were passaged for three days to expand the culture. Frozen
stocks of equal passage number (passage 4) were stored at -80°C for all experiments.
C2C12 and mouse embryonic fibroblast (MEF) cells were maintained in growth medium
(GM) which consisted of Dulbecco‟s Modified Eagles Medium (DMEM) supplemented
with 15% Fetal Bovine Serum and 1% penicillin/streptomycin (50:100 units penicillin,
50:100 μg streptomycin; Invitrogen) (Growth Medium, GM). HeLa cells were maintained
in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin. All cells were
kept in a humidified 37°C incubator injected with 5% carbon dioxide. For each
experiment, a fresh vial of C2C12 cells was thawed, plated in a 100mm x 20mm culture
dish and grown for approximately 36 hours until the cells reached 60-70% confluency.
MEF and HeLa cells were grown in 100mm x 20mm culture dishes and were passaged
when the cells obtained 70-80% confluency. To passage MEF and HeLa, cells were first
briefly washed three times with phosphate buffered saline (PBS; 137 mM NaCl; 2.7 mM
KCl; 4.3 mM Na2HPO4; 1.47 mM KH2PO4, pH 7.4). Following washing, the cells were
incubated with trypsin-EDTA (Invitrogen; 0.25% trypsin solution) for 3 minutes at 37°C
with minimal agitation. Approximately 5 mL of DMEM + 15% FBS was added to
inactivate the trypsin, and the suspension was transferred to a 15 mL conical tube and
centrifuged at 1500 rpm for 2 minutes. The supernatant was removed by aspiration and
the pellet was resuspended with 5 mL of DMEM + 15% FBS. The cells were then either
plated into fresh 100 mm x 20 mm culture dishes or counted and plated into well dishes
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for experiments.

3.2 Plating Cells
To plate cells for differentiation time courses, siRNA depletion experiments, YFPfusion protein overexpression experiments and all other experiments, the cells were first
collected from the 100 mm x 20 mm culture dishes, centrifuged, and resupsended as
previously described. Ten microliters of the cell suspension was loaded onto each side
of a Bright-Line Hemocytometer and the cells were counted and averaged to determine
cell concentration. Cells were diluted to the appropriate concentration with DMEM+ 15%
(for C2C12)or 10% FBS (for HeLa or MEF) and plated in wells with coverslips for
processing for immunofluorescence and live cell imaging, or without coverslips for
protein and RNA extraction. For all differentiation time course studies, 2x105 C2C12
cells were plated in 35mm dishes. For all MEF and HeLa immunofluorescence
experiments, 1x105 cells were plated in 35mm dishes. For siRNA experiments, 1x105
C2C12, MEF, and HeLa cells were plated in each well of 24-well dishes. For live cell
imaging optimization experiments, 2.5x105 C2C12 cells were plated onto each well of a
6-well dish. For live imaging, 5x105 C2C12 cells were plated into each 60 mm x 15 mm
dish.
3.3 Coverslip Preparation
All coverslips were cleaned thoroughly by washing in one part nitric acid and two
parts hydrochloric acid for approximately 2 hours with occasional stirring; continuous
rinsing in distilled water was done until the pH returned to approximately 7.0. The
coverslips were then stored in 70% ethanol and flamed prior to use. Coverslips to be
used with C2C12 cells were treated with 0.001% Poly-L-lysine (Sigma) for five minutes
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at room temperature. The mixture was removed by aspiration, the coverslips were dried
for 30 minutes at room temperature, and washed three times for 5 minutes each with
PBS at room temperature. The coverslips were either used immediately or stored at 4°C.
3.4 Induction of C2C12 Differentiation
C2C12 differentiation was induced via serum deprivation or self-induction through
cell-to-cell contact (Yaffe and Saxel, 1977). For induction of differentiation using serum
deprivation, the cells were plated one day prior to inducing differentiation (Day -1) in GM.
Differentiation was induced on Day 0 of the time course by removing GM and washing
briefly three times with PBS to remove any remaining GM. Differentiation was then
induced with the addition of differentiation medium (DM) consisting of DMEM
supplemented with 2% Horse Serum and antibiotics streptomycin and penicillin. For selfinduction of C2C12 differentiation, cells were plated at 3.5x105 C2C12 in 35mm dishes.
Cells were maintained in GM throughout the entire differentiation time course and GM
was replenished every 48 hours. Cells were monitored daily for the formation of
myotubes as an indication that differentiation was proceeding normally.
3.5 Immunofluorescence
C2C12 cells were washed briefly three times with PBS and fixed with 2%
formaldehyde (2 grams paraformaldehyde dissolved into 100 mL PBS) for 15 minutes at
room temperature. Cells were washed 3 x 5 minutes with PBS. Cells were permeabilized
with 0.2% Triton X-100 in PBS for 10 minutes and washed 3 x 5 minutes in PBS + 0.5%
normal goat serum (NGS; Gibco) at room temperature. Cells were incubated with
primary antibodies WU10 (anti-Btf, 1:1000), WU13 (anti-Son, 1:1000), human antinucleolar antibody (anti-fibrillarin , 1:500; Sigma Aldrich, St. Louis, MO), monoclonal F5D
(anti-myogenin,1:500; University of Iowa Developmental Studies Hybridoma Bank, Iowa
32

City, IA), monocolonal MF20 (anti-MHC, 1:1000; University of Iowa Developmental
Studies Hybridoma Bank, Iowa City, IA), monocolonal anti-fibrillarin (1:500; Abcam,
Cambridge, MA), and anti-Asym 25 (1:100, provided by Jocelyn Cote, University of
Ottowa, Ottowa, Ontario) for 1 h at room temperature in a humidified chamber. Cells
were washed 3 x 5 minutes with PBS + 0.5% NGS and incubated with either FITC-,
Texas Red-, or Cy5-conjugated secondary antibodies (1:2000; Jackson
Immunoresearch Laboratory) for 1 h at room temperature in a dark, humidified chamber.
Cells were washed once in PBS + 0.5% NGS, then with PBS + DAPI (10μg/ml) in PBS in
the second wash. Coverslips were mounted using 12 µl of mounting medium containing
anti-fade (polyphenylinediamine), sealed with nail polish, and stored at -80°C. HeLa cells
were processed the same as C2C12 cells with the exception that permeabilization was
performed for 5 minutes. MEFs were also processed the same as C2C12 cells but
fixation was done with 4% formaldehyde.
3.6 Microscopy
The cells were imaged used a DeltaVision RT real time restoration system (Applied
Precision) with PLAN-APO oil, 1.4 N.A. objectives (Olympus). C2C12 cells were imaged
with a 40x objective lens and MEF and HeLa cells were imaged with a 60x objective
lens. Images were obtained with a cool snap CCD camera and SoftWorx Explorer Suite
was used for visualization and processing. Z-stacks consisting of 0.2 µm increments
through the z-plane of the cells were displayed as a volume projection to include all
images from the z-stack of interest. For live imaging, z-stacks were collected at 30
minute intervals in 0.30 µm increments throughout the entire depth of all C2C12 nuclei
within a region of interest.
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3.7 Whole Cell Nuclear Extract Preparation
C2C12 cells for immunoprecipitation experiments were extracted using the whole
cell nuclear extract (WCNE) protocol established by Wysocka et al. (2003). The cells
were removed from the plate by applying PBS to the cells and scraping using a rubber
policeman. The cells were then placed in an eppendorf tube and centrifuged for 5
minutes at 1200 rpm. Lysis buffer [300mM NaCl, 100mM Tris (pH 8.0), 0.2mM EDTA
(pH 8.0), 0.1% NP40, 10% glycerol and protease inhibitor cocktail (Pierce, 1 tablet per
10 ml of lysis buffer added freshly prior to cell extraction] was added to the pellet and
incubated at 4°C on a tube rotator. After incubation with lysis buffer, the extract was
centrifuged for 10 minutes at 14,000 rpm at 4°C and the supernatant was collected and
stored at -80ºC.
3.8 Protein Extraction, Bradford Assays, and SDS-PAGE
Cells were washed with PBS and scraped from the dish using 1ml of PBS and a rubber
policeman. The wells were then washed with additional PBS, the samples were
collected, centrifuged at 4°C for 5 minutes in a clinical centrifuge at 1200 rpm, the
supernatant was removed, the pellet washed with additional PBS, and the samples
centrifuged again for 1 minute. The supernatant was removed, the pellet was
resuspended with 50-100 µl of RNase-free water, an equal volume of 2x Laemmli buffer
(4% SDS, 20% glycerol, 1.4M β-mercaptoethanol, 0.125 M Tris HCl, and bromophenol
blue) was added, and the samples were stored at -80°C. Before Bradford Assays were
performed, the protein samples were boiled for 5 minutes to denature the proteins. For
the Bradford Assays, standards of 1µg, 2µg, 5µg, 10µg, and 20µg of BSA were prepared
in distilled water in a total volume of 4µl. 2µl of cell extract was mixed with distilled water
for a total volume of 4µl. 496µl of water and 500µl of Thermo Scientific Coomassie Plus
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Protein Assay Reagent were then added for a final volume of 1mL. Samples were
loaded into 1 mL cuvettes and absorbance was measured at λ495 on a Milton Roy
Spectronic 1001 Plus. A graph of OD versus µg protein was plotted with the standard
samples and a best fit line was applied. Once protein concentrations of experimental
samples were determined using absorbance readings and the standard curve, 40ug of
each sample was loaded into the wells of a 10% or 15% poly-acrylamide gel [resolving
gel: 10% or 15% Degassed acrylamide/bis, 0.125 M Tris HCl (pH 8.8), 0.1% SDS;
stacking gel: 10% Degassed acrylamide/bis, 0.125 M Tris HCl (pH 6.8), 0.1% SDS], and
gel electrophoresis was performed in Running Buffer [30 mM Tris HCL, 144 mM glycine,
0.01% SDS] at 150 V for approximately one hour. Precision Plus protein ladder
purchased from BioRad served as the molecular mass marker. The proteins were then
transferred from the polyacrylamide running gel to a nitrocellulose membrane at 200 mA
for 90 minutes using chilled Transfer Buffer (Running Buffer containing 20% methanol).
Ponceau (0.5% Ponceau S, 1% acetic acid) staining was used to confirm successful
transfer and to mark well lanes and marker. The nitrocellulose membrane was blocked
to avoid non-specific binding of antibodies using PBST [0.22 M sodium phosphate
monobasic, 1.2 M sodium phosphate dibasic anhydrous, 137 mM sodium chloride, and
1.0% Tween] and 5% non-fat dry milk. The membrane was then cut horizontally to
separate the region of the membrane with the protein of interest and the protein used as
equal loading control to allow for dual probing. Primary antibodies were diluted in 5%
non-fat dry milk in PBST, applied to the membrane, and incubated for 1 hour at room
temperature. The membrane was washed 3 x 5 minutes with PBST on a shaker, and
species-specific antibodies conjugated with horseradish peroxidase (HRP) diluted in
PBST + 5% nonfat dry milk were applied to the membrane and incubated for 1 hour at
room temperature on a shaker. The membrane was washed 3 x 5 minutes with PBST
the membrane was developed using Thermo Scientific Pierce ECL Western Blotting
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Substrate. The blot was then imaged on Fuji LAS- 4000 Luminescent Image Analyzer
(Fujifilm Life Science USA, Stamford, CT).
3.9 RNA Extraction
Cells to be harvested for RNA extraction were plated as described above. All
RNA extractions were performed using Qiagen RNeasy reagents and supplied protocols.
DMEM was removed from cells and collected in 15 ml conical tubes. The cells were
washed briefly with PBS, incubated with trypsin, collected using 1 mL DMEM, and
centrifuged for 2 minutes in a conical centrifuge at 1500 rpm. The supernatant was
removed, the pellet was washed with PBS, the samples were centrifuged again for 2
minutes in a conical centrifuge at 1500 rpm, and supernatant was removed. Pellets were
resuspended with 350ul of Qiagen RNeasy RLT buffer and vortexed for 1 minute. 350µl
of 70% ethanol was added and 700 µl of the sample was loaded into a RNeasy spin
column and centrifuged for 15 seconds at 1600 rpm. 700 µl of Qiagen RNeasy RW1
buffer was added to the column and centrifuged as before. 500ul of Qiagen RNeasy
RPE buffer was added to the column, centrifuged as before, and an additional 500ul of
RPE buffer was added to the column and centrifuged for 2 minutes at 1600 rpm. To
elute the RNA, 30µl of RNase-free water was applied directly to the spin column
membrane and centrifuged for 1 minute. This step was repeated and the eluted RNA
was stored at -80°C.
3.10 Midi Prep and Restriction Digest of Plasmid DNA Preparation
All plasmid preparations were done with Promega‟s Wizard‟s® Plus Midipreps
DNA Purification System. Plasmid DNA for transfection was isolated from glycerol stocks
of E. coli cultures containing respective plasmids that were prepared by previous lab
members. E. coli from glycerol stocks was added to 3 mL cultures of sterile LB Broth
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supplemented with 1 µl/mL of either ampicillin or kanamycin as appropriate for each
plasmid and incubated overnight in an orbital shaker at 37°C. 2mL of the 3mL overnight
suspension was added to 100 mL of sterile LB Broth and incubated as before. The 100
mL culture was transferred to a sterile 250 mL centrifuge tube and centrifuged at 10,000
RCF‟s for 10 minutes at 4°C and the supernatant was removed. The pellet was
resupsended in 3 mL of Promega Resuspension Buffer, followed by 3 mL of Promega
Lysis Buffer and finally 3 mL of Promega Neutralization Buffer. The suspension was
centrifuged again at 14,000 RCF‟s for 15 minutes and the supernatant was decanted
through filter paper into a fresh 50mL Falcon tube. 10mL of Promega Purification Resin
was added to the supernatant, then the mixture was transferred into a Promega Midiprep column and a vacuum source was applied. The DNA-bound resin was washed
twice with 15 mL of Promega Wash Buffer. DNA was eluted with 300 µl of 65-70°C
RNase-free water. The DNA was then precipitated out by adding 30 µl of 3.0mM sodium
acetate and 900µl of 95% ethanol and incubated at -20°C for at least four hours. The
DNA was then centrifuged at 1600 rpm for five minutes, the supernatant was removed,
and the pellet was washed with 95% ethanol, and centrifuged again as described above.
The supernatant was removed and the pellet was allowed to dry, 200 µl TE was added
to dissolve the DNA. DNA was then quantified using ND-1000 Spectrophotometer
NanoDrop. Plasmid identity was confirmed by digesting DNA with appropriate restriction
enzymes at 37ºC for two hours. 6x loading dye was added to each digested plasmid
sample and loaded onto an 1% agarose gel containing ethidium bromide and run at 70V
for 1 hour. Gels were then imaged using a Fotodyne camera with an ethidium bromide
filter and Foto/UV 26 gel box. Gel images were processed using PC Image software.
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3.11 Transfection of DNA by Electroporation
C2C12 cells were cultured, collected, and counted as previously described. Cells
were resuspended in electroporation buffer [EB; 1x HBS, 5uM CaCl] at a concentration
of 5x105 cells per 250 µl of EB. Appropriate concentrations of plasmid DNA and salmon
sperm DNA (see chart below) were added to each 4 mm gap cuvette and incubated for
one minute and then 250 µl of cells in EB were added to each cuvette.

Plasmid

µg of Plasmid DNA

µg of Salmon Sperm DNA

CFP-Fibrillarin

4

80

YFP-Btf

4

80

YFP-SF2

4

60

C2C12 cells were electroporated using a BioRad GenePulser XCell [220V, 950µF, and
0Ω]. Cells were incubated on ice for 10 minutes post-electroporation, resuspended in 1
mL of DMEM per cuvette, and plated.
3.12 RNA Interference
Cells were plated as previously described in antibiotic-free DMEM supplemented with
10% FBS. siRNA transfection was done 24 hours after cells were plated. HeLa and
C2C12 cells were transfected using Gibco 1x Opti-MEM, Invitrogen Oligofectamine
Reagent, Dharmacon 1x siRNA buffer, 20µM Luciferase oligo [Dharmacon], and 20 µM
human siRNA oligo 2 (hsi-2) [Dharmacon] as follows:
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Condition

Tube 1

Tube 2

Mock

15µl Oligofectamine

250µl Opti-MEM

60µl Opti-MEM

15µl siRNA Buffer

15µl Oligofectamine

250µl Opti-MEM

60µl Opti-MEM

15µl 20µM Luciferase oligo

15µl Oligofectamine

250µl Opti-MEM

60µl Opti-MEM

15µl 20µM msi-1

15µl Oligofectamine

250µl Opti-MEM

60µl Opti-MEM

15µl 20µM hsi-2

Control

Mouse si-1siRNA duplex

Human si-2 siRNA duplex

Contents were added to each tube and incubated for 5 minutes at room temperature.
Contents of Tube 2 were added to Tube 1 and incubated for 20 minutes at room
temperature. 340 µl of each mixture was added to appropriate wells. HeLa and C2C12
cells were incubated for 24 hours and then processed. For C2C12 differentiation time
course studies, differentiation was induced via serum deprivation (in DM) 24 hours posttransfection. Mock, control, msi-1, and hsi-2 samples were processed at Day 0, Day 2,
and Day 4 of the differentiation time course for immunofluorescence, protein extraction,
and RNA extraction.

3.13

Live Cell Microscopy

C2C12 were cultured, plated, and electroporated as described above. Differentiation
was induced in DM 12 hours post-transfection and imaging began ~30 hours into the
differentiation time course. The coverslip was removed from GM and loaded onto the live
cell chamber apparatus and perfused with Leibovitz‟s L-15 Medium (Invitrogen)
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supplemented with 2% HS. Cells were imaged with the DeltaVision RT system using
point visiting every 30 minutes for 8 hours using CFP and YFP channels. Images were
displayed as time-lapse videos.
3.14 Nucleoli and Mitotic Counts
Nucleoli counts were performed on fixed cells processed by immunofluorescence for
visualization of fibrillarin. For C2C12 cells, 50 myoblast nuclei and 50 myotube nuclei
were randomly selected by blindly selecting areas of the coverslip for image capture.
Each nucleus selected was then scored for the number of nucleoli present as indicated
by fibrillarin staining. MHC or myogenin-negative cells were scored as undifferentiated
cells. Cells positive for MHC or myogenin were scored as differentiating cells. These
counts were done for each day of the differentiation time course. These counts were
done for three separate time courses, the counts were averaged, and standard deviation
was determined. For HeLa and MEF counts, 50 nuclei from both “high serum” (10%
FBS) and „low serum” (0.5% FBS) were scored for number of nucleoli for each day of the
4 day time course. Counts from C2C12, HeLa and MEF cells were plotted on a graph of
# Nuclei versus # Nucleoli. Mitotic counts were performed by randomly selecting 50
nuclei as described above and determining the number of mitotic cells present out of the
50 nuclei selected. Percentage of mitotic cells present was determined for C2C12, HeLa,
and MEF cells, and displayed in charts.
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Chapter 4: Examining Btf’s Role in Myogenesis
4.1 Btf Expression Increases During Myogenesis in C2C12 Cells
To begin to understand if Btf has a role in myogenesis, I examined Btf in
differentiating C2C12 cells. C2C12 cells were plated, allowed to attach for 24 hours, and
induced to differentiate by switching from growth medium (GM) to differentiation medium
(DM). C2C12 cells were processed for immunofluorescence on Day 0 at the time on
induction through Day 4 of the differentiation time course to immunolabel Btf as well as
muscle specific proteins myogenin and MHC. Myogenin and MHC served as markers to
indicate myoblasts undergoing differentiation. Cells that were positive for expression of
myogenin exhibited increased nuclear labeling of Btf as compared to neighboring
undifferentiated myoblasts (Figure 4.1). Increased nuclear labeling of Btf was detected in
some cells that were not MHC positive but all cells which were positive for myogenin
showed increased nuclear labeling of Btf (Figure 4.1 and 4.2). Increased nuclear labeling
of Btf was also observed in myoblasts that had not yet fused into multinucleated
myotubes (Figure 4.1 and 4.2). Immunofluorescence data taken together with
immunoblot data collected by Alok Sharma (Figure 2.1) suggests that increased
expression of Btf is an early event in the differentiation process. While the immunoblot
shows globally that Btf expression increases, IF data indicates that the increase is seen
in the myoblasts undergoing differentiation (myoblasts which stain positive for musclespecific proteins that serve as differentiation markers). Increased expression of Btf
persisted through Day 4 of the
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Figure 4.1. Expression of Btf and Myogenin in differentiating C2C12 cells. After
differentiation was induced, myoblasts began to show nuclear expression of musclespecific protein myogenin. Expression of myogenin appeared as early as Day 0 in
spontaneously differentiating cells (Panels A-D, arrows, red signal indicates
immunolabeling of myogenin with F5D anti-myogenin antibody). As early as Day 0, cells
positive for myogenin exhibited a higher level of Btf labeling (Panels A-D, arrows, green
signal indicates immunolabeling of Btf with WU10 antibody) as compared to neighboring
undifferentiating cells (Panels A-D, arrowheads). Increased labeling of Btf in
differentiating myoblasts persisted through Days 3 and 4 in nuclei of myotubes (Panels
M-P, arrows) and Day 4 (Panels Q-T, arrows). DNA was stained with DAPI. Boxed
regions are enlarged in the lower set of panels shown at each time point. Bar = 5µm.
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Figure 4.2. Expression of Btf and MHC in differentiating C2C12 cells. After
differentiation was induced, myoblasts began to show cytoplasmic expression of musclespecific protein myosin heavy chain (MHC). Expression of MHC appeared as early as
Day 1 and marked myoblasts undergoing differentiation (Panels E-H, arrows, red signal
indicates immunolabeling of MHC with MF20 antibody). By Day 2, differentiating
myoblasts (Panels I-L, arrows) exhibited higher levels of nuclear Btf as compared to
neighboring MHC-negative myoblasts (Panels I-L, arrow heads, green signal indicates
immunolabeling of Btf with WU10 antibody). By Day 4, MHC positive cells were more
prevalent and fused into multinucleated myofibrils. DNA was stained with DAPI. Bar =
5µm
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differentiation time course (Figure 4.1 and Figure 4.2). All cells throughout the entire
differentiation time course which were positive for muscle specific proteins myogenin or
MHC exhibited increased nuclear labeling of Btf.
4.2 Overexpression of Btf Alone does Not Induce Differentiation of C2C12 Cells
Because Btf expression increases early in C2C12 differentiation, we wanted to
test whether increased expression of Btf alone might alternatively shift the timing of
differentiation events in C2C12 cells maintained in GM. C2C12 cells were transfected
with empty YFP plasmid DNA or YFP-Btf plasmid DNA via electroporation. C2C12 cells
transfected with empty YFP plasmid DNA were maintained in GM for the entire time
course as a control to assert that transfection alone did not alter the uninduced
differentiation time course. Cells transfected with YFP-Btf were divided into two groups,
one that was maintained in GM and another that was induced to differentiate by
switching to DM. C2C12 cells transfected with empty YFP plasmid DNA served as a
control to assert that any changes seen in samples transfected with YFP-Btf were not
simply a result of the transfection process or YFP expression, but indeed a result of Btf
overexpression. C2C12 cells that were transfected with YFP-Btf and induced to
differentiate were used to verify that transfected cells could undergo differentiation and
to compare the time course of transfected cells to that of a normal time course in terms
of muscle specific protein expression and gross morphological changes. In addition to
transfected samples, untransfected C2C12 cells were either maintained in GM or
induced to differentiate on Day 0 of the time course by switching to DM. Untransfected
cells were induced to differentiate in parallel and served as a normal differentiation time
course comparison. Untransfected cells maintained in GM were used to determine the
frequency of spontaneous differentiation of transfected cells that were not induced. By
including all of these conditions, it was possible to compare the differentiation time
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courses of cells overexpressing Btf (uninduced and induced) to normally differentiating
untransfected cells (induced or uninduced), and note any changes in differentiation
timing, cellular phenotypes, or expression of marker proteins of interest.
A summary of the overall experimental design for Btf overexpression can be
found in Figure 4.3. Cells from all groups were processed for immunolabeling on Day 0,
Day 2, and Day 4 of the time course. Transfected C2C12 cells were processed for
immunoflourescence labeling of muscle specific proteins myogenin and MHC.
Transfected cells were observed for expression of myogenin and MHC as well as
exogenous Btf. Untransfected cells were processed for immunofluorescence labeling of
both endogenous Btf as well as muscle specific proteins myogenin and MHC. Cells that
were transfected with empty YFP plasmid DNA and cells that were transfected with YFPBtf and maintained in GM showed no expression of muscle specific proteins myogenin
or MHC until Day 4 of the time course (Figure 4.4 – Figure 4.9), indicating that
spontaneous differentiation was infrequent in this experiment. Progression of the
differentiation time course in cells that were not induced to differentiate appeared
delayed in comparison to normal differentiation time courses in which myogenin
expression occurs at Day 1 and MHC expression occurs at Day 2. Untransfected C2C12
cells maintained in GM also showed no expression of muscle specific proteins myogenin
or MHC until Day 4 of the time course which indicates that delayed differentiation
observed in transfected cells maintained in GM was not a result of transfection or
overexpression of Btf (Figure 4.6 and Figure 4.9). It is worth noting that all C2C12 cells
that were maintained in GM failed to form multinucleated myotubes by Day 4 (Figure 4.6
and Figure 4.9). Cells that were transfected with YFP-Btf and were induced to
differentiate showed expression of both myogenin and MHC at Day 2 of the time course
(Figure 4.5 and Figure 4.8) and increased through Day 4 (Figure 4.6 and Figure 4.9)
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Figure 4.3. Overexpression of Btf experimental design. C2C12 myoblasts were
divided into five groups. A portion of C2C12 myoblasts were transfected with the
parental plasmid containing only the YFP protein sequence and were maintained in
growth medium (DMEM + 15% FBS, GM) for the entire experiment. C2C12 cells were
also transfected with the YFP-Btf plasmid and half of the samples were induced to
differentiate via serum deprivation and the other half was maintained in GM for the entire
experiment. Untransfected C2C12 cells were divided into two groups and one group was
induced to differentiate via serum deprivation for a normal time course and one group
was maintained in GM for the entire experiment. Abbreviations for experimental
conditions are provided in parentheses.
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Figure 4.4. Overexpression of Btf and expression of myogenin at Day 0 of the
differentiation time course. At Day 0 of the time course, none of the experimental
conditions showed nuclear expression of muscle specific protein myogenin (red signal
indicates immunolabeling of myogenin with F5D antibody). Both untransfected cells
maintained in GM (Panels M-P, arrows) and untransfected cells induced to differentiate
(Panels Q-T, arrows) contain mitotic cells indicating the cells are still in a proliferative
state. DNA was stained with DAPI. Bar = 5μm.
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Figure 4.5. Overexpression of Btf and expression of myogenin at Day 2 of the
differentiation time course. At Day 2 of the differentiation time course, all cells which
were maintained in GM still did not exhibit expression of muscle specific protein
myogenin. Cells transfected with YFP-Btf and induced to differentiate (Panels E-H,
arrows, red signal indicates immunolabeling of myogenin with F5D antibody) and
untransfected cells which were induced to differentiate (Panels Q-T, arrows) contain
cells positive for myogenin as expected of cells after 48 hours of serum deprivation
indicating a normal differentiation time course. DNA was stained with DAPI. Bar = 5μm.
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Figure 4.6. Overexpression of Btf and expression of myogenin at Day 4 of the
differentiation time course. Four days after the time course was started, all samples
contain myoblasts positive for muscle specific protein myogenin. Cells transfected with
empty YFP and maintained in GM were positive for myogenin at Day 4 (Panels A-D,
arrows, green signal indicates expression of exogenous YFP) as were surrounding cells
which were not successfully transfected (Panels A-D, arrowheads) indicating that
transfection of YFP did not hinder the myoblast‟s ability to differentiate. Cells transfected
with YFP-Btf and induced to differentiate (Panels E-H) showed multiple myogenin
positive myoblasts which had fused into myotubes. Cells transfected with YFP-Btf and
maintained in GM (Panels I-L, arrows, green signal indicates expression of YFP-Btf)
exhibited expression levels of myogenin (red signal indicates immunolabeling of
myogenin with F5D antibody) similar to untransfected cells maintained in GM.
Untransfected cells that were induced to differentiate showed a normal progression of
the differentiation time course (Panels Q-T). DNA was stained with DAPI. Bar = 5μm.
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Figure 4.7. Overexpression of Btf and expression of MHC at Day 0 of the
differentiation time course. Cells transfected with empty YFP and maintained in GM
(Panels A-D, green signal indicates expression of exogenous YFP) and cells transfected
with YFP-Btf and maintained in GM (Panels I-L, green signal indicates expression of
YFP-Btf) were negative for cytoplasmic expression of MHC (red signal indicates
immunolabeling of MHC with MF20 antibody) as were untransfected cells maintained in
GM (Panels M-P, green signal indicates immunolabeling of endogenous Btf with WU10
antibody). Cells transfected with YFP-Btf that were induced to differentiate (Panels E-H)
as well as cells that were not transfected and induced to differentiatecells (Panels Q-T)
showed no expression of MHC as expected at Day 0 of the differentiation time course.
The presence of mitotic cells in untransfected cells that were induced to differentiate
(Panels Q-T, arrows) indicate that differentiation had not been activated. DNA was
stained with DAPI. Bar = 5μm.
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Figure 4.8. Overexpression of Btf and expression of MHC at Day 2 of the
differentiation time course. Cells transfected with empty YFP plasmid and maintained
in GM (Panels A-D) and cells transfected with YFP-Btf and maintained in GM (Panels IL) were negative for MHC expression at Day 2. Cells transfected with YFP-Btf and
induced to differentiate (Panels E-H, green signal indicates expression of YFP-Btf) and
untransfected cells induced to differentiate (Panels Q-T, green signal indicates
immunolabeling of endogenous Btf with WU10 antibody) showed the greatest number of
MHC positive cells as expected. One myoblast in the untransfected cells maintained in
GM was positive for MHC indicating that some spontaneous differentiation was occurring
in this experiment (Panels M-P, arrows, red signal indicates immunolabeling of MHC
with MF20 antibody). DNA was stained with DAPI. Bar = 5μm.
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Figure 4.9. Overexpression of Btf and expression of MHC at Day 4 of the
differentiation time course. By Day 4 of the time course, all experimental groups
contained myoblasts positive for MHC expression (all Panels, red signal indicates
immunolabeling of MHC with MF20 antibody). Cells in all groups that were induced to
differentiate formed multi-nucleated myotubes, whereas cells in all groups maintained in
GM did not form multi-nucleated myotubes. DNA was stained with DAPI. Bar = 5μm.
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which reflected normal timing of the differentiation time course. Untransfected C2C12
cells that were induced to differentiate exhibited expression of myogenin and MHC at
Day 2 and increased through Day 4 of the time course confirming the cells were
undergoing normal differentiation (Figure 4.5 and Figure 4.6). All C2C12 cells that were
induced to differentiate formed multinucleated myotubes by Day 4 of the time course as
expected (Figure 4.6 and Figure 4.9). It is also worth noting that by Day 4, both induced
and uninduced cells overexpressing YFP-Btf exhibit myotubes containing nuclei both
positive for overexpression and negative for overexpression of YFP-Btf (Figure 4.9,
Panels E-L). Endogenous Btf expression levels for all induced samples and all
uninduced samples were similar as observed by immunoblot data (Figure 4.10). This
suggests that all induced or uninduced time courses proceeded with similar timing
regardless of overexpression of YFP or YFP-Btf and that overexpression of YFP-Btf
produced no observable changes in endogenous Btf levels throughout the differentiation
time course. Immunoblotting using an anti-GFP antibody which recognizes the YFP tag
confirmed that YFP-Btf was overexpressed in the C2C12 cells.
In addition to expression of muscle specific proteins and changes in gross
morphology, all experimental samples were observed for presence of mitotic cells to
determine if the cells were cycling or had exited the cell cycle. In order to differentiate,
cells must first exit the cell cycle; therefore, observing the number of mitotic cells in a
population served as an indicator of differentiation. All cells that were maintained in GM
for the duration of the experiment exhibited a higher number of mitotic cells as compared
to cells that were induced to differentiate (Table 4.1). A lower number of mitotic cells was
expected for cells induced to differentiate because in order to differentiate the cells must
first exit the cell cycle. A higher proportion of mitotic cells in cells that were transfected
with YFP-Btf maintained in GM suggests that overexpression of Btf alone was not
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Figure 4.10. Western blot analysis to detect expression of endogenous Btf
throughout time course testing the effect of Btf overexpression on differentiation.
WCNE was prepared on Day 0, Day 2, and Day 4 of the differentiation time course.
Equal total protein in each sample was loaded onto SDS-PAGE and transferred to a
nitrocellulose membrane for immunoblotting. At Day 0 of the time course, Btf signal is
undetectable in all samples as expected. By Day 2 of the time course Btf is detectable in
cells which were transfected with YFP-Btf and induced to differentiate and untransfected
cells which were induced to differentiate. A detectible signal for Btf is still absent at Day
2 for all other samples which were maintained in GM throughout the entire time course.
By Day 4 of the time course Btf is detectable in all samples.
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Table 4.1. Mitotic counts for all experimental conditions in Btf overexpression time
course. One hundred cells were randomly selected for image capture and mitotic cells
were counted for each experimental condition in the Btf overexpression time course.
This process was repeated for cells co-labeled with myogenin and MHC. C2C12 cells
which were transfected with the YFP plasmid and maintained in growth medium (DMEM
+ 15% FBS, GM) showed an overall decrease in mitotic cells but still possessed more
mitotic cells at Day 4 than any of the experimental groups in which differentiation was
induced. C2C12 cells which were transfected with YFP-Btf and induced to differentiate
decreased greatly in their mitotic population from Day 0 to Day 4. C2C12 cells which
were transfected with YFP-Btf and grown in GM maintained approximately the same
number of mitotic cells during the time course. C2C12 cells that were not transfected but
were induced to differentiate showed an almost complete absense of mitotic cells at day
2 and Day 4. C2C12 cells which were neither transfected nor induced to differentiate
maintained an approximately consistent mitotic population.
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capable of inducing the cells to exit the cell cycle and progress along the differentiation
pathway.

4.3 Ineffective Knockdown of Btf Using siRNA
Because Btf protein expression increases early during C2C12 differentiation, we
wondered if Btf depletion might hinder differentiation. Undifferentiated C2C12 cells have
a very low baseline level of Btf; therefore, determining whether Btf siRNA duplexes could
effectively knock down Btf in undifferentiated cells would be difficult. In order to optimize
depletion of Btf, preliminary experiments were done using HeLa and mouse embryonic
fibroblasts (MEFs). HeLa cells were used as a control to confirm that I could produce a
successful depletion because other lab members have optimized effective depletion of
Btf in HeLa cells. MEFs were used because they are a mouse cell line with higher
baseline levels of Btf in which to test oligos targeted against mouse Btf mRNA. Upon
examination of the mouse Btf sequence, it was discovered that an oligo targeted against
human Btf, hsi-2, matched a sequence within mouse Btf and was used along with four
oligos targeted towards mouse Btf (msi-1-4). Preliminary experiments showed that in
MEF cells, hsi-2 showed nearly complete depletion of Btf and msi-1 showed partial
depletion of Btf (Figure 4.12). In addition to immunoblot data, immunoflourescence data
confirmed that in MEF cells, hsi-2 was the most effective at knocking down Btf, and msi1 was also partially effective. Once the most effective oligos were chosen, we designed
an experiment to deplete Btf and induce differentiation in C2C12 cells, as shown in the
experimental design summary in Figure 4.11. C2C12 cells were transfected with siRNA
buffer (mock), siRNA oligos targeted against luciferase (control), and siRNA oligos
targeted against Btf (hsi-2) and incubated for 24 hours. Mock-treated cells served as a
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Figure 4.11. Btf depletion via siRNA interference experimental design. C2C12
myoblasts were transfected with either siRNA buffer (mock), siRNA oligos targeted
against luciferase (control), or siRNA oligos targeted against Btf (hsi-2) and allowed to
incubate for 24 hours. 24 hours after siRNA transfection (Day 0), C2C12 myoblasts were
induced to differentitate and processed for immunolabeling of Btf and muscle specific
proteins myogenin and MHC as well as protein extraction for immunoblotting. Cells were
processed as described above again at Day 2 and Day 4 of the differentiation time
course.
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Figure 4.12 Depletion of Btf via siRNA in mouse embryonic fibroblasts (MEFs).
MEF cells were transfected with siRNA buffer (mock), siRNA oligos targeted against
luciferase (control), and mouse Btf (msi-1 – msi-4) and human Btf (hsi-2) and extracted
for SDS-PAGE 48 hours after transfection. Btf was detected at ~150 kDa in mock and
control cells. Btf. Cells treated with siRNA oligo 1 targeted against mouse Btf (msi-1)
showed a slight depletion of Btf. Cells treated with siRNA oligo 2 targeted against human
Btf (his-2) showed nearly complete depletion of Btf. Actin was used as a loading control.
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control to assert that vehicle alone did not hinder differentiation. siRNA oligos targeting
luciferase were used to control for any general off-target effects of the siRNA
transfection. C2C12 cells were then processed for immunofluorescence labeling of Btf
and muscle specific protein MHC on Day 0, Day 2 and Day 4 of the differentiation time
course (Figure 4.11). Muscle specific protein MHC served as a marker to indicate cells
undergoing differentiation. All C2C12 cells showed no expression of MHC on Day 0 of
the differentiation time course as expected (Figure 4.13). By Day 2 of the differentiation
time course, all experimental conditions showed myoblasts positive for MHC and an
increased level of Btf expression (Figure 4.13). By Day 4 of the differentiation time
course, all experimental conditions showed multinucleated myotubes (Figure 4.13). For
all days of the differentiation time course myoblasts that were treated with siRNA oligos
targeted against Btf did not show depletion of Btf (Figure 4.13). Different concentrations
of siRNA reagents and post-transfection incubation periods in multiple experiments all
yielded the same results; however, siRNA depletion of Btf was successful in MEF and
HeLa cells. Undifferentiated C2C12 cells have very low basal levels of Btf; therefore,
detecting depletion of Btf in undifferentiated C2C12 cells is very difficult and the cells
were allowed to differentiate in order to determine if depletion had occured. For future
attempts of this project I might recommend attempting siRNA transfection via
electroporation given that ineffective depletion of Btf might have been a result of poor
transfection efficiency, as C2C12 cells are notoriously hard to transfect, and
electroporation conditions have been optimized which yield high transfection efficiency in
C2C12 cells.
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Figure 4.13. Btf depletion with siRNA duplex was ineffective in C2C12. C2C12 cells
were transfected with siRNA buffer (mock), siRNA oligos targeted against luciferase
(control), and Btf (hsi-2) and processed 48 hours later for Day 0. At Day 0, cells treated
with hsi-2 oligos targeted against Btf showed no apparent depletion of Btf (panels Aa,
Ae, and Ai, green signal indicates immunolabeling of Btf with WU10 antibody and red
signal indicates immunolabeling of MHC with MF20 antibody). At Day 2 and Day 4, Btf
still does not appear to be depleted (Panels Ba, Be, Bi, Ca, Ce, and Ci), as the
fluorescence labeling of Btf is similar among controls and his-2-treated cells. DNA was
stained with DAPI. Bar = 5μm.
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Chapter 5: Investigating Nuclear Reorganization in C2C12 Cells
5.1 Nuclear Speckles Reorganize During Myogenesis in C2C12 Cells.
A preliminary experiment performed by an undergraduate honors student
revealed reorganization of nuclear speckles during C2C12 differentiation (Theadore
Hufford and Paula Bubulya, unpublished data). To confirm observations seen in the
preliminary experiment and further investigate nuclear reorganization during
differentiation of C2C12 myoblasts, I performed differentiation time course experiments
to study organization of nuclear speckles throughout differentiation. C2C12 myoblasts
were plated, allowed to attach for 24 hours, and induced to differentiate on Day 0 by
switching from growth medium (GM) to differentiation medium (DM). C2C12 cells were
processed Day 0 through Day 4 for immunofluorescence labeling of nuclear speckle
protein Son as well as muscle specific proteins myogenin and MHC. Muscle specific
proteins myogenin and MHC served as markers to indicate differentiating myoblasts. As
early as Day 0, myoblasts positive for myogenin exhibited more defined, larger, and
brighter nuclear speckles in comparison to neighboring undifferentiated myoblasts that
showed punctuate nuclear speckle labeling (Figure 5.1). Some MHC negative cells
exhibited reorganized nuclear speckles (Figure 5.2). This data taken together with the
fact that reorganized nuclear speckles were observed in myoblasts which had not yet
fused into multinucleated myotubes suggests that nuclear speckle reorganization occurs
is early in the differentiation time course.
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Figure 5.1. Reorganization of nuclear speckles in differentiating myoblasts
expressing myogenin. After induction of differentiation, myoblasts begin to exhibit
nuclear expression of muscle specific protein myogenin. By Day 2 of the differentiation
time course, cells positive for myogenin (Panels I-L, arrows, red signal indicates
immunolabeling of muscle specific protein myogenin with F5D anti-myogenin antibody)
exhibit a more defined speckle phenotype (green signal indicates immunolabling of
nuclear speckle protein Son with polyclonal WU13 antibody) as compared to neighboring
undifferentiated myoblasts (Panels I-L, arrowheads). DNA was stained with DAPI. Bar =
5µm.
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Figure 5.2. Reorganization of nuclear speckles in differentiating myoblasts
expressing MHC. Approximately 48 hours after induction of differentiation, myoblasts
begin to exhibit cytoplasmic expression of the muscle-specific protein MHC. Myoblasts
positive for MHC (Panels I-L, arrows, red signal indicates immunlabeling of MHC with
MF20 anti-MHC antibody) exhibit a more defined speckle phenotype (green signal
indicates immunolabling of nuclear speckle protein Son with polyclonal WU13 antibody)
as compared to neighboring undifferentiated myoblasts (Panels I-L, arrowheads). DNA
was stained with DAPI. Bar = 5µm.
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5.2 Nucleoli Reorganize During Myogenesis in C2C12 Cells.
In addition to nuclear speckles, preliminary data showed that nucleoli in
differentiating C2C12 cells reorganize (Theadore Hufford and Paula Bubulya,
unpublished data). In order to confirm this data and further characterize nucleolar
reorganization, I performed differentiation time course experiments in which I monitored
nuclear expression and compartmentalization of rRNA processing factor fibrillarin.
C2C12 myoblasts were plated, allowed to attach for 24 hours, and induced to
differentiate on Day 0 by switching from GM to DM. C2C12 cells were processed on Day
0 through Day 4 for immunofluorescence labeling of fibrillarin as well as for muscle
specific proteins myogenin and MHC. Myogenin and MHC served as markers to
indicate differentiating myoblasts. Myogenin positive cells were present at Day 0 and
Day 1; however, myogenin positive cells on Day 0 and Day 1 did not show a
reorganization of nucleoli (Figure 5.3). By Day 2 of the differentiation time course,
myogenin positive myoblasts showed a reorganization of nucleoli from approximately 510 small punctate bodies to approximately 1-5 more prominent bodies (Figure 5.3).
Some cells that were MHC negative exhibited reorganized nucleoli (Figure 5.4). Both
fibrillarin and MHC are labeled in Texas Red secondary antibody because both
antibodies were monoclonal antibodies and because the two proteins are in separate
compartments of the cells, one secondary was used. Reorganized nucleoli were
observed in cells which had not yet fused into multinucleated myotubes (Figure 5.4).
Some spontaneously inducing cells also exhibited the reorganized phenotype (Theadore
Hufford, Paula Bubulya, unpublished data). This data suggests that nucleolar
reorganization occurs earlier in the differentiation time course than MHC expression and
multinucleation.
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Figure 5.3. Reorganization of nucleoli in differentiating myoblasts expressing
myogenin. After induction of differentiation, myoblasts begin to show nuclear expression
of muscle specific protein myogenin. By Day 2, all myoblasts positive for myogenin
(Panels I-L, arrows, green signal indicates immunolabeling of myogenin with F5D antimyogenin antibody) exhibit a change in nucleolar organization (Panels I-L, arrows, red
signal indicates immunolabeling of nucleolar component fibrillarin with polyclonal antifibrillarin antibody) as compared to neighboring undifferentiated myoblasts (Panels I-L,
arrowheads). DNA was stained with DAPI. Bar = 5μm.
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Figure 5.4. Reorganization of nucleoli in differentiating myoblasts expressing
MHC. Beginning on Day 1 of the differentiation time course nucleoli in differentiating
myoblasts reorganize. By Day 1 of the differentiation time course, the cell indicated is
negative for MHC expression (Panels D-F, arrows, red signal indicates immunolabeling
of both MHC with MF20 anti-MHC antioby and fibrillarin with monoclonal anti-fibrillarin
antibody) but still exhibits a reorganized nucleolar phenotype as compared to
neighboring cells (Panels D-F, arrowheads). DNA was stained with DAPI. Bar = 5µm.
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5.3 Chromocenters reorganize during myogenesis in C2C12 cells
In addition to nuclear speckles and nucleoli, chromocenters in differentiating
nuclei reorganized. Chromocenter reorganization and spatial clustering has been
previously reported (Terranova et al., 2005). In undifferentiated C2C12 cells,
chromocenters are evenly distributed throughout the nucleoplasm. However, as the
myoblasts progress along the differentiation pathway chromocenters redistribute to the
periphery of the nuclei. Throughout the various time course experiments performed, we
observed in undifferentiated C2C12 cells the chromocenters were evenly distributed
throughout the nucleoplasm. An example of this from one time experiment can be found
in Figure 5.5, panel A. Once cells had differentiated, the chromocenters were distributed
predominately on the periphery of the nuclei as previously reported.
5.4 Nuclear reorganization is not an artifact of serum starvation.
To assert that nuclear reorganization observed in differentiating C2C12 cells was
not an artifact of serum starvation, I performed experiments using to test the effects of
serum starvation on both HeLa and mouse embryonic fibroblast (MEF) cells. HeLa cells
were chosen because they are a non-mouse cell line that does not undergo the
differentiation process; furthermore, by using this cell line I could determine if serum
starvation causes nuclear reorganization in a non-mouse cell line not undergoing
differentiation. If nuclear reorganization occurred in serum-starved HeLa cells it would
suggest that the nuclear reorganization I observed in differentiating C2C12 cells was a
result of serum starvation rather than a specific differentiation event. MEF cells were
chosen because they are a mouse cell line that does not undergo the differentiation
process; furthermore, nuclear reorganization occurring in serum-starved MEF cells
would suggest that nuclear reorganization in response to serum starvation was a mouse
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Figure 5.5. Chromocenters reorganize during myoblast differentiation in C2C12
cells. At Day 0 of the differentiation time course chromocenters in undifferentiated cells
are evenly distributed throughout the nucleoplasm (Panel A, white signal indicates DNA
staining by DAPI). By Day 4 of the differentiation time course, chromocenters in
differentiated cells have reorganized and are located predominately at the periphery of
the nuclei (Panel B, white signal indicates DNA staining by DAPI). Bar = 5μm.
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cell-specific phenomenon. HeLa and MEF cells were maintained in both “high serum”
(DMEM + 10% FBS) and “low serum” (DMEM + 0.5% FBS) for four days. On each day,
HeLa and MEF cells maintained in both serum conditions were processed for
immunofluorescence labeling of both nuclear speckle protein Son and nucleolar protein
fibrillarin to simultaneously monitor nuclear speckle and nucleolar organization. Because
HeLa and MEF cells do not undergo differentiation, no proteins were used to mark cells
undergoing differentiation. HeLa cells maintained in high serum conditions showed no
reorganization of nuclear speckle morphology or nucleolar morphology between Day 1
and Day 4 (Figure 5.6). HeLa cells maintained low serum conditions exhibited no
changes in nuclear speckle morphology or nucleolar morphology between Day 1 and
Day 4 (Figure 5.7). MEF cells maintained in high serum conditions showed no
reorganization of nuclear speckle or nucleolar morphology between Day 1 and Day 4 of
the time course (Figure 5.8). MEF cells maintained in low serum conditions also showed
no reorganization of nuclear speckle morphology or nucleolar morphology (Figure 5.9).
Lack of nuclear speckle and nucleolar reorganization in either HeLa or MEF cells
suggests that nuclear reorganization as observed in differentiating C2C12 cells was not
an artifact of serum starvation. Because C2C12 cells undergoing differentiation show a
decrease over time in the number of nucleoli per nucleus, I scored HeLa and MEF cells
maintained in high and low serum conditions for number of nucleoli per nuclei for each
day of the experiment. HeLa cells that were maintained in either high serum or low
serum conditions showed no shift in the average number of nucleoli per nucleus
between Day 1 and Day 4 indicating HeLa cell nucleoli do not reorganize as C2C12 cell
nucleoli do during differentiation (Figure 5.10). MEF cells which were maintained in
either high serum or low serum conditions showed no shift in average number of nucleoli
per nucleus between Day 1 and Day 4 (5.11). Mitotic cells were scored for each
experimental group for Day 1 through Day 4 to determine if cells maintained in either
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Figure 5.6. Nuclear Organization in HeLa cells maintained in normal serum
conditions. HeLa cells maintained in DMEM + 10% FBS showed no changes in
organization of nuclear speckles (green signal indicates immunolabeling of nuclear
speckle protein Son with polyclonal WU13 antibody) between Day 1 (Panels A, C and D,
arrows) and Day 4 (Panels M, O, and P, arrows). Cells maintained in the same
conditions also do not show changes in organization of nucleoli (red signal indicates
immunolabeling of nucleolar component fibrillarin with monoclonal anti-fibrillarin
antibody) between Day 1 (Panels B-D, arrowheads) and Day 4 (Panels N- P,
arrowheads). DNA was stained with DAPI. Bar = 5μm.

89

90

Figure 5.7. Serum starvation does not result in reorganization of HeLa nuclei.
HeLa cells maintained in DMEM + 0.5% FBS (low serum conditions) showed unaltered
organization of nuclear speckles (green signal indicates immunolabeling of nuclear
speckle protein Son with polyclonal WU13 antibody) between Day 1 (Panels A, B, and
D, arrows) and Day 4 (Panels M, O, and P, arrows). Cells maintained in the same
conditions also exhibit unchanged organization of nucleoli (red signal indicates
immunlabeling of nucleolar component fibrillarin with monoclonal anti-fibrillarin antibody)
between Day 1 (Panels B-D, arrowheads) and Day 4 (Panels N-P, arrowheads). DNA
was stained with DAPI. Bar = 5μm.
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Figure 5.8. Nuclear organization of mouse embryonic fibroblasts (MEFs)
maintained in normal serum conditions. MEFs maintained in DMEM + 10% FBS
showed unaltered organization of nuclear speckles (green signal indicates
immunolabeling of nuclear speckle protein Son with polyclonal WU13 antibody) between
Day 1 (Panels A, C, and D, arrows) and Day 4 (Panels M, O, and P, arrows). Cells
maintained in the same conditions also exhibit unchanged organization of nucleoli (red
signal indicates immunolabeling of nucleolar component fibrillarin with monoclonal antifibrillarin antibody) between Day 1 (Panles B-D, arrowheads) and Day 4 (Panels N-P,
arrowheads. DNA was stained with DAPI. Bar = 5μm.
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Figure 5.9. Serum starvation does not result in reorganization of MEF nuclei. MEFs
maintained in DMEM + 0.5% FBS showed unaltered organization of nuclear speckles
(green signal indicates immunolabeling of nuclear speckle protein Son with polyclonal
WU13 antibody) between Day 1 (Panels A, C, and D, arrows) and Day 4 (Panels M, O,
and P, arrows). Cells maintained in the same conditions also exhibit unchanged
organization of nucleoli (red signal indicates immunlabeling of nucleolar component
fibrillarin with monoclonal anti-fibrillarin antibody) between Day 1 (Panles B-D,
arrowheads) and Day 4 (Panels N-P, arrowheads. DNA was stained with DAPI. Bar =
5μm.
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Figure 5.10. Number of Nucleoli per Nuclei Does Not Change For HeLa Cells In
Response To Serum Starvation. HeLa cells maintained in either high serum
concentrations (DMEM + 10% FBS, gray bars) or low serum concentrations (DMEM +
0.5% FBS, black bars) do not exhibit any difference in average number of nucleoli per
nucleus between Day 1 (Panel A) through Day 4 (Panel D).
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Figure 5.11. Number of nucleoli per MEF nucleus does not change for MEF Cells
after serum starvation. MEFs maintained in both high serum concentrations (DMEM +
10% FBS, gray bars) and low serum concentrations (DMEM + 0.5% FBS, black bars) do
not exhibit a shift in average number of nucleoli per nuclei between Day 1 (Panel A)
through Day 4 (Panel D).
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high or low serum conditions were actively cycling. Mitotic cells were scored for HeLa
cells maintained in both high serum and low serum conditions for all four days of the
time course. HeLa cells which were maintained in high serum conditions showed an
overall increase in number of mitotic cells present within the population and HeLa cells
maintained in low serum conditions shifted from 2% to 4% (Table 5.1). Mitotic cells were
scored for MEF cells maintained in either high serum or low serum conditions for all four
days of the time course. MEF cells maintained in high serum conditions showed an
overall increase in number of mitotic cells present within the population and MEF cells
maintained in low serum conditions showed a decrease of mitotic cells from 2% on Day
1 to 0% on Day 4 (Table 5.1). A lower percentage of mitotic cells in both HeLa and MEF
cells maintained in low serum conditions as compared to HeLa and MEF cells
maintained in high serum conditions was expected because serum starved cells stop
proliferating.
5.5. Nuclear speckles and nucleoli reorganize in differenitiating myoblasts in the
absence of serum starvation.
To further assert that nuclear reorganization was not an artifact of serum
starvation in C2C12 cells, I performed a time course experiment in which C2C12
myoblasts were plated at a higher density to allow for increased cell-to cell contact. Cellto cell contact among undifferentiated C2C12 cells leads to spontaneous differentiation
in the absence of serum starvation. Additional C2C12 cells that were plated at the
normal density and were induced to differentiate via serum starvation served as a control
to which I could compare myoblasts undergoing self-induced differentiation. At Day 0 of
the differentiation time course, no cells exhibited any nuclear reorganization as expected
(Figure 5.12, panels A-D and Figure 5.13, panels A-C). By Day 4 of the time course,
cells which were induced to differentiate via serum starvation exhibited reorganized
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Table 5.1. Mitotic Counts for HeLa, MEF, and C2C12 Cells. Fifty cells were randomly
selected for image capture and mitotic cells were counted for each cell line for all days of
the serum test experiment. MEF cells maintained in high serum conditions exhibited an
overall increase in the mitotic population from Day 1 (with 10% mitotic cells) through Day
4 (with 14% mitotic cells). MEF cells maintained in low serum conditions show an overall
decrease in the mitotic population beginning with 2% mitotic cells on Day 1 and ending
with 0% mitotic cells on Day 4. HeLa cells maintained in high serum concentrations also
showed an overall increase in the mitotic population beginning with 6% on Day 1 and
ending with 20% on Day 4. HeLa cells maintained in low serum concentrations showed
an overall 2% increase in mitotic populations but still had a lower percentage in
comparison to all cell lines maintained in high serum concentrations. Upon induction to
differentiate via serum starvation, the mitotic population of C2C12 cells decreased from
14% on Day 0 to 0% by Day 4 and remained at 0% through Day 8 after addition of
growth medium for four days.
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Figure 5.12. Nuclear speckles reorganize in differentiating C2C12 cells in the
absence of serum starvation. On Day 0 of the differentiation time course, both cells
which were induced to differentiate through either cell-to cell contact (self-induced) or
serum starvation showed no reorganization of nuclear speckles (Panels A-D and I-L,
green signal indicates immunolabeling of nuclear speckle protein with WU13 antibody
and red signal indicates immunolabeling of muscle specific protein myogenin with antimyogenin antibody). By Day 4 of the differentiation time course both self-induced and
serum starved cells exhibited equivalent reorganization of nuclear speckles. DNA was
stained with DAPI. Bar = 5μm.
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Figure 5.13. Nucleoli reorganize in differentiating C2C12 cells in the absence of
serum starvation. On Day 0 of the differentiation time course, both cells which were
induced to differentiate through either cell-to cell contact (self-induced) or serum
starvation showed no reorganization of nucleoli (Panels A-D and I-L, red signal indicates
immunolabeling of nucleolar component fibrillarin with monoclonal anti-fibrillarin antibody
and MHC with MF20 anti-MHC antibody). By Day 4 of the differentiation time course
both self-induced and serum starved cells exhibited equivalent reorganization of nucleoli
(Panels E-H and M-P). DNA was stained with DAPI. Bar = 5μm.
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nuclear speckles and nucleoli consistent with previous experiments (Figure 5.12, panels
E-H and Figure 5.13, panels D-F). By Day 3 of the differentiation time course, the cells
undergoing self-induced differentiation were processed as they had developed myotubes
and were nearly 100% confluent as observed by phase contrast microscopy. At Day 3 of
the differentiation time course, the self-induced cells showed reorganization of both
nuclear speckles and nucleoli as observed in the serum starved cells (Figure 5.12,
panels M-P and Figure 5.13, panels J-K). This data suggests that the nuclear
reorganization observed in differentiating C2C12 cells is not a result of the metabolic
changes that occur during serum starvation but rather a result of the differentiation
process.
5.6. The number of nucleoli per nucleus decreases in an irreversible fashion
during differentiation.
To determine if nuclear reorganization was reversible, I performed experiments in which
GM was added back to C2C12 cells after Day 4 of the differentiation time course.
C2C12 cells were scored for number of nucleoli per nuclei in both myoblasts (cells that
were negative for muscle specific proteins myogenin or MHC) and myotubes (cells that
were positive for muscle specific proteins myogenin or MHC) for Days 0-4 of the
differentiation time course. Myotubes consistently had fewer nucleoli per nucleus in
comparison to myoblasts for all four days of the differentiation time course (Figure 5.14).
On Day 4 of one differentiation time course, GM was added back to the C2C12 cells for
four additional days and the number of nucleoli per nucleus was again scored for both
myoblasts and myotubes on Day 8. Myotubes again showed fewer nucleoli per nuclei
(Figure 5.14). Failure of nucleoli to revert to the organization seen in undifferentiated
C2C12 cells in the presence of GM suggests that nuclear reorganization is irreversible.
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Figure 5.14. Differentiation causes irreversible nucleolar reorganization in C2C12
myoblasts. For each day of the differentiation time course, 30 myoblast (C2C12 cells
negative for myogenin or MHC) and 30 myotube (C2C12 cells positive for myogenin or
MHC) nuclei were counted and number of nucleoli per nuclei was recorded. This was
repeated for three separate experiments (1 fibrillarin + myogenin, 2 fibrillarin + MHC)
and the number of nucleoli per nuclei averaged. Myotubes consistently show a lower
number of nucleoli, while myoblasts exhibit a higher number of nucleoli (Panels A-E).
For one time course experiment, at Day 4 of differentiation, growth medium was added
back to the cells and on Day 8 the cells were fixed and counted as previously stated to
determine if nuclear reorganization would reverse when serum-rich medium was added
back to the cells. Nucleoli counts on Day 8 indicate that nucleolar reorganization
resulting from differentiation is similar to that on Day 4 (Panel F).
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5.7. Live imaging of nuclear reorganization
Based on observations made of reorganization of nuclear speckles and nucleoli, we
hypothesized two possible models for reorganization: nuclear domain fusion and/or
nuclear domain recession and enlargement. In order to determine which model was
correct, we designed experiments to image nucleolar reorganization via live cell
microscopy. To our knowledge live imaging in C2C12 cells has not been previously
done. As such, several parameters were optimized to increase the probability for
successful imaging of nuclear proteins including transfection conditions and timing of
transfection in the differentiation scheme. C2C12 cells were transfected with CFPfibrillarin plasmid DNA for live imaging of exogenous protein. To optimize transfection
conditions, C2C12 cells were first transfected with 40 μg of salmon sperm carrier DNA
and increasing amounts of plasmid DNA ranging from 2 µg-10 μg. C2C12 cells
transfected with 4 μg of CFP-fibrillarin DNA provided the greatest level of transfection
efficiency (Figure 5.15). C2C12 cells transfected with 40 µg of salmon sperm carrier
DNA and 4 µg of CFP-fibrillarin DNA exhibited high transfection efficiency but high levels
of overexpression were also observed and seemed to alter nucleolar reorganization
(data not shown). The goal of this optimization was to express enough CFP-fibrillarin for
image detection without altering nuclear structure. To optimize salmon sperm carrier
DNA concentrations in order decrease overexpression, C2C12 cells were then
transfected with 20 µg, 40 µg, 60 µg and 80 μg of salmon sperm carrier DNA. 80 µg of
salmon sperm carrier DNA provided the greatest transfection efficiency and lowest but
detectable levels of overexpression (Figure 5.15). C2C12 cells were transfected with
CFP-fibrillarin and induced to differentiate 48 hours later. To limit phototoxicity in live
imaging, it is important to establish a minimal time frame for examining reorganization.
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Figure 5.15. Optimization for transfection of CFP-fibrillarin plasmid DNA via
electroporation. C2C12 cells were first transfected with varying amounts of CFPfibrillarin plasmid DNA and 40 μg of salmon sperm carrier DNA. Following plasmid
optimization, varying amounts of salmon sperm carrier DNA were used to transfect
plasmid DNA. C2C12 cells transfected with 4 μg of plasmid DNA and 80 μg of salmon
sperm carrier DNA exhibited the highest transfection efficiency and lowest levels of
overexpression.
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Cells were fixed at the time of differentiation induction and every 8 hours after that to
determine a window of time during which the nucleolar phenotype changed. The
nucleolar phenotype reorganized approximately 32-40 hours after the cells were induced
to differentiate (Figure 5.16). Untransfected C2C12 cells were fixed alongside
transfected samples and immunolabeled for fibrillarin to determine if exogenous and
endogenous fibrillarin protein showed similar reorganization behavior and timing
throughout the differentiation time course. Endogenous fibrillarin also showed that
nuclear reorganization occurred between approximately 32-40 hours after the cells were
induced to differentiate indicating that exogenous and endogenous protein exhibits
similar timing throughout the differentiation time course (Figure 5.16). Because our
approach involved transient transfection, and because live imaging was not started until
30 hours after differentiation was induced (as established by Figure 5.16), we wanted to
know how soon after transfection CFP-fibrillarin was detectable in C2C12 cells to avoid
possible loss of detectable CFP-fibrillarin expression during live imaging. C2C12 cells
were then transfected by using the optimized conditions (Figure 5.15) and were fixed at
12 hours, 24 hours, 36 hours and 48 hours after transfection. Expression of CFPfibrillarin was detectable at the earliest monitored time point of 12 hours post-transfection
(Figure 5.17). This experiment showed that it is not necessary to wait 48 hours after
transfection for inducing differentiation, as the optimal timing for imaging begins at 12
hours after transfection. To image nucleolar reorganization in C2C12 cells, C2C12 cells
were transfected with 4 μg of CFP-fibrillarin DNA and 80 μg of salmon sperm carrier
DNA. Differentiation was induced 12 hours after transfection and live imaging was
started 30 hours after induction and continued through 40 hours after induction. In order
to image nuclear speckles and Cajal bodies, optimization experiments similar to those
done with CFP-fibrillarin were performed for transfection of YFP-SF2/ASF and GFP-
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Figure 5.16. Time track of nucleolar reorganization phenotype. C2C12 cells were
transfected with CFP-fibrillarin and induced to differentiate 48 hours after transfection.
Upon induction to differentiate, cells were fixed in 2% formaldehyde at 24 hours (Panel
A, a), 32 hours (Panel B, b), and 40 hours (Figure 5.16A, panel c). At approximately 32
hours after induction of differentiation nucleoli start to exhibit a change in nucleolar
organization. Untransfected cells were processed alongside samples electroporated with
CFP-fibrillarin for comparison of endogenous and exogenous fibrillarin protein
localization patterns as well as the timing for nucleolar reorganization. Untransfected
samples were immunolabeled for fibrillarin (green signal indicates immunolabeling of
fibrillarin). 32 hours after induction of differentiation, some myoblasts begin to exhibit a
reorganized phenotype (Figure 5.16B, panels g-i, arrows) while other myoblasts still
exhibit the undifferentiated phenotype (Figure 5.16B, panels g-I, arrowheads). By 40
hours after induction, the majority of the myoblasts exhibit the reorganized phenotype
(Figure 5.16B, panels j-I, arrows). DNA was stained with DAPI. Bar = 5μm.
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Figure 5.17. Determining how long after transfection expression of CFP-fibrillarin
persists. C2C12 cells were transfected with CFP-fibrillarin and fixed at 12 hours (A), 24
hours (B), 36 hours (C), and 48 hours after transfection. Expression of CFP-fibrillarin
was detectible at 12 hours after transfection in some myoblasts (Panel A) and increased
through 48 hours (Panel D). DAPI was not used due to bleed through between the CFP
and DAPI channels on the microscope. Bar = 5μm.
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coilin in C2C12 cells. Optimization of YFP-SF2/ASF revealed that transfection of 4μg of
YFP-SF2/ASF plasmid DNA and 60 μg of salmon sperm carrier DNA yielded the highest
transfection efficiency with the lowest levels of exogenous expression Figure 5.18).
Significant overexpression of exogenous fusion proteins was avoided to ensure that any
observed changes in nuclear organization would not be attributed to elevated levels of
fusion proteins. Optimization experiments with GFP-coilin showed that GFP-coilin does
not localize conclusively to Cajal bodies in C2C12 cells (Figure 5.19).
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Figure 5.18. Optimization of transfection of YFP-SF2/ASF plasmid DNA via
electroporation. C2C12 cells were transfected with 60 μg of Salmon Sperm carrier DNA
and 4 μg (Panel Aa-Ac), 6 μg (Panels Ad-Af), and 8 μg (Panels Ah-Ai) YFP-SF2/ASF
DNA. C2C12 cells were also transfected with 80 μg of Salmon Sperm carrier DNA and
C2C12 cells transfected with 60 μg of salmon sperm carrier DNA and 4 μg (Panel BaBc), 6 μg (Panels Bd-Bf), and 8 μg (Panels Bg-Bi). Bar = 5μm.
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Figure 5.19. GFP-coilin does not localize correctly in C2C12 cells. C2C12 cells were
transfected with 60μg of salmon sperm carrier DNA and varrying amounts of GFP-Coilin
plasmid DNA (A) as well as 80μg of salmon sperm carrier DNA and varying amounts of
GFP-Colin plasmid DNA (B). In all cells transfected, GFP-coilin failed to localize to Cajal
bodies. DNA was stained with DAPI. Bar = 5μm.
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Chapter Six: Discussion
Emery-Dreifuss is one of three major forms of muscular dystrophy and is an Xlinked disorder that arises from defects in nuclear-associated proteins, most notably
emerin (Fairley et al., 1999). A subset of EMDM patients exhibit mutation in emerin, and
they demonstrate normal expression levels and subcellular localization of emerin at the
inner nuclear membrane. This is in contrast to the majority of EMDM patients whom
produce no detectable emerin as observed by immunoblotting and
immunohistochemistry (Haraguchi et al., 2004). This set of mutations includes a serine
to phenylalanine substitution at residue 54 (S54F), a proline to histidine substitution at
residue 183, a deletion of residues 95-99 (Δ95-99), and a proline to threonine
substitution at residue 183 (Haraguchi et al., 2004). Two of these mutations, S54F and
Δ95-99 have been mapped to regions of emerin that associate with Btf fragments by
yeast-two-hybrid assay (Haraguchi et al., 2004). Given Btf‟s possible role in EDMD, I set
out to investigate a possible role for Btf in muscle cells. Initial experiments revealed that
Btf is upregulated during muscle cell differentiation; furthermore, surprising changes in
nuclear organization during differentiation were discovered (Theadore Hufford and Paula
Bubulya, unpublished data).
In order to elucidate a possible role for Btf in muscle cells, I performed
differentiation time courses throughout which I immunolabeled Btf and muscle specific
proteins myogenin and MHC. Myogenin expression in the nucleus increases early in the
differentiation time course with expression increasing at approximately Day 1 of the time
course. MHC expression in the cytoplasm increases later in the differentiation time
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course at approximately Day 3; however, MHC expression has been observed at Day 2
in a limited number of myoblasts. Using these two muscle markers allowed us to classify
increased expression of Btf as an early or late event the differentiation time course.
Throughout the differentiation time course all cells which were positive for either
myogenin or MHC showed increased expression levels of Btf. Increased expression
levels of Btf was determined to be an early event in the differentiation time course. Upon
first observation, it appeared that all myogenin positive myoblasts were also positive for
increased expression levels of Btf. However, many MHC positive myoblasts were not
positive for increased levels of expression. To quantify this, 100 myogenin positive cells
were scored for the presence or absence of increased expression levels of Btf and all
100 myogenin positive myoblasts were also positive for increased expression levels of
Btf. In addition, I could not locate any myogenin negative myoblasts which were positive
for increased expression levels of Btf. No parallel counts were done for myoblasts
immunolabeled for MHC and Btf because it can be assumed based on the differentiation
time line that if MHC is present, myogenin must also be present as it precedes MHC in
the differentiation time course and increased expression of Btf is always present when
myogenin is present. However, numerous MHC negative cells were observed to be
positive for increased expression levels of Btf. This data together indicates that
increased expression of Btf occurs either simultaneously with increased myogenin
expression or very soon after increased myogenin expression and before increased
MHC expression. Given that increased expression levels of Btf is an early event in the
differentiation time course, we wanted to determine if overexpression of Btf could alone
lead to the increased expression of muscle markers myogenin and MHC and drive the
differentiation pathway.
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To determine if overexpression of Btf was capable of inducing differentiation in
the absence of serum deprivation, Btf was overexpressed in C2C12 cells and
maintained in GM. C2C12 cells were also transfected with YFP plasmid DNA to rule out
transfection alone as the cause of any alterations observed in C2C12 cells transfected
with YFP-Btf plasmid DNA. C2C12 cells were also transfected with YFP-Btf and induced
to differentiate via serum deprivation to confirm that cells overexpressing Btf were
capable of differentiating and that overexpression of Btf did not speed up or slow down
the differentiation time course. Untransfected C2C12 cells were maintained in growth
medium to ensure that any observations made in transfected samples which were not
induced to differentiate would not occur normally in C2C12 cells without serum
starvation. Another group of untransfected C2C12 cells were induced to diffentiate to
serve as a direct comparison to a normal differentiation time course.
According to immunfluorescence data, cells which were transfected with YFP
plasmid DNA, YFP-Btf DNA and not induced to differentiate, and untransfected cells
which were not induced to differentiate showed very slight differentiation by Day 4
indicating that overexpression of Btf alone was not enough to induce differentiation.
Furthermore, by Day 4 of the time course we observe transfected myoblasts
incorporated into myotubes with other non-transfected myoblasts indicating that they are
still competent to differentiate and are indistinguishable to other non-transfected
myobasts (Figure 4.19). Given that both transfected and untransfected samples which
were not induced to differentiate showed similar levels of differentiation indicates that
transfection did not hinder the cells‟ ability to differentiate. C2C12 cells which were
transfected with YFP-Btf and induced to differentiate and untransfected cells which were
induced to differentiate exhibited similar levels of differentiation at Day 0, Day 2, and Day
4 indicating that overexpression of Btf neither slowed down or expedited differentiation.

126

In addition to immunolabeling for muscle specific proteins, future repetitions of this
experiment could be repeated including duplicates of each sample that are
immunolabeled for both nuclear speckle protein Son and nucleolar component fibrillarin
to observe for nuclear reorganization as another dimension of differentiation.
Immunoblot data in this experiment seems to correlate with the
immunofluorescence data in that cells which were transfected with YFP-Btf and not
induced to differentiate show equivalent Btf expression with untransfected and
uninduced samples. This data indicates that in the absence of serum starvation cells
overexpressing Btf progress along the differentiation pathway at the same rate as the
uninduced differentiation time course. In order to confirm YFP-Btf was truly
overexpressed, the blot was re-probed to detect the YFP signal. Repeated attempts
failed to show an YFP signal on the blot; however, using immunofluorescence data, 100
myoblasts that were transfected with YFP-Btf and not induced to differentiate and 100
myoblasts that were transfected with YFP-Btf and induced to differentiate were scored
on Day 0 of the differentiation time course. Day 0 was chosen because the transfection
was transient so Day 0 was the time point at which successfully transfected cells would
be present at the highest levels. In cells that were transfected with YFP-Btf and not
induced to differentiate 42/100 myoblasts were positive for YFP-Btf. In cells that were
transfected with YFP-Btf and induced to differentiate 39/100 myoblasts were positive for
YFP-Btf. Once a myoblast has started the differentiation program, that myoblast will
signal any other myoblast it comes into cell-to cell contact with to differentiate as well.
Therefore, given the rate of transfection and that the cells were approximately 50-60%
confluent at Day 0 it is reasonable to conclude that enough transfected cells were
present and were in close enough proximity to untransfected cells to cause a observable
change in the differentiation time course if overexpression of Btf did indeed alter the
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differentiation time course. In addition to probing for endogenous Btf, this immunoblot
could be probed for muscle specific proteins myogenin and MHC to further confirm or
refute that the differentiation time course is not expedited or hindered by overexpression
of YFP-Btf. When examining the immunoblot data there is one discrepancy between the
immunoblot and immunofluorescence data. At Day 0 in the immunofluorescence data
there appears to be a slight signal for endogenous Btf; however, in the immunoblot there
is no baseline signal for Btf at Day 0 in any of the samples. This discrepancy could have
resulted from the fact that the WU10 anti-Btf antibody is more sensitive or effective at
detecting Btf protein in the immunofluorescence method versus the immunoblot method.
Many antibodies are known to work more effectively or exclusively for one method or the
other. Another irregularity found within the blot is the absence of a second Btf band. Give
that the YFP-tag adds molecular weight to the protein another band indicating
exogenous Btf should be found slightly above the endogenous Btf band; however, no
band was present. One final unexpected piece of data found within the immunoblot
corresponds to the Btf signal for cells which were not transfected and not induced to
differentiate at Day 4. This sample shows a much more intense signal for endogenous
Btf. If this signal truly correlates to a higher expression level of Btf in these cells, it would
be worthwhile in future experiments to see if myoblasts which were not induced to
differentiate consistently show higher expression levels of Btf in comparison to other
myoblasts that were induced to differentiate by Day 4 of the differentiation time course. If
this were the case, it would be valuble to investigate a possible role for Btf in promoting
cycling in cells. In order to test this theory, one could overexpress YFP-Btf in a number
of cells lines that do not differentiate and compare mitotic indices of the cells
overexpressing YFP-Btf to each cell line‟s baseline mitotic index.
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Together, the immunofluorescence and immunobot data indicates that increased
expression levels of Btf do not alter the differentiation time course. It must be considered
that the YFP- tag on the Btf protein might interfere with the function of Btf in this
instance. However, immunoprecipitation experiments performed by other students in our
lab showed that YFP-Btf formed complexes with nuclear membrane protein emerin just
as endogenous Btf does (Lauren Ford, Kelly Conti and Paula Bubulya, unpublished
data). Furthermore, this experiment showed that myoblasts overexpressing Btf were still
competent to differentiate and form myotubes along with myoblasts expressing
endogenous Btf. Together this data indicates to us that the function of Btf is most likely
not hindered by the YFP tag. However, given that no information regarding Btf‟s tertiary
structure is available, it must remain a possibility that the placement of the YFP tag may
interfere with some unknown functions of Btf in vivo.
Protein depletion is one of the most basic molecular approaches to elucidating a
protein‟s function. In order to determine a possible role or function for Btf in myogenesis,
we designed experiments to deplete Btf mRNA (and thereby Btf protein) using a
lipofectamine-mediated transfection. In order to ensure that these experiments were
effective, I first performed siRNA depletion of Btf in HeLa cells using a previously
established protocol from our lab. These experiments were successful and showed that
in my hands I could produce a successful depletion of Btf. To begin optimizing the
protocol for mouse cells, I first performed experiments in which I depleted Btf in mouse
embryonic fibroblasts (MEFs). MEFs were used because undifferentiated C2C12 cells
have nearly undetectable baseline levels of Btf; however, baseline levels of Btf in MEFs
are much higher. This eliminated the complication of optimizing depletion of Btf in
C2C12 cells while attempting to differentiate which would be nearly impossible. While
optimizing the protocol in MEFs, four different siRNA oligos targeted against mouse Btf
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were tested as well as one siRNA oligo targeted against human Btf which was identical
in sequence to a portion of the mouse Btf sequence. These experiments revealed that
the siRNA oligo targeted against human Btf (hsi-2) produced complete knockdown of Btf
in MEFs as detected by immunoblot. After numerous attempts using the optimized
conditions, siRNA transfection failed to produce effective knockdown of Btf in C2C12
cells as observed by both immunofluorescence and immunoblot. The inability to produce
an effective knockdown of Btf in C2C12 cells is not surprising because C2C12 cells are
notoriously hard to transfect and special products are often needed to increase the
efficiency of lipofectamine-mediated transfection. In the future, it might be more useful to
use electroporation as the method of transfection because a successful electroporation
protocol for C2C12 cells has been established. Depletion of Btf in HeLa and MEF cells
takes approximately 72 hours; therefore, even if successful depletion of Btf was
achieved in C2C12 cells, by the time Btf was depleted the cells would most likely
become too confluent and spontaneous differentiation could occur. If the experimental
conditions can‟t be controlled, such as induction of differentiation, then the experiment
will not produce reliable results and that data would be rendered useless. In addition to
immunoblot data, incorporating RT-PCR data to examine RNA levels of Btf following
siRNA transfection would be helpful. If the RT-PCR results revealed that Btf was
depleted at the RNA level it might be interesting to investigate the turnover rate and halflife of the Btf protein through fluorescence recovery after photobleaching (FRAP) and
cyclohexamide studies. Although the siRNA transfection did not effectively deplete Btf,
this was an important experiment to attempt given that expression levels of Btf increase
early in muscle cell differentiation and therefore may have a vital function in myogenesis.
If depletion of Btf had been successful and sequential experiments showed that in the
absence of Btf C2C12 cells failed to differentiate in response to serum starvation this
would have indicated that Btf does play an essential role in myogenesis. If previously
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proposed experiments in which YFP-Btf was overexpressed in various cell lines revealed
Btf positively regulated cell proliferation, it would be interesting to see if successful
depletion of Btf could result in C2C12 differentiation in the absence of serum starvation.
In order to study nuclear reorganization in differentiating C2C12 myoblasts, I
focused on tracking nuclear speckles and nucleoli throughout differentiation. Throughout
differentiation of C2C12 myoblasts, nuclear speckles reorganized from a diffuse pattern
to a more defined, large, and bright pattern as observed by immunofluorescence
microscopy (Figures 4.1 and 4.2). Myogenin is upregulated earlier in the differentiation
time course, by Day 1 (Figure 2.1) and MHC is upregulated later at Day 2 of the
differentiation time course. Using these two muscle specific proteins to label
differentiating myoblasts, I was able to conclude that nuclear speckle reorganization
occurs at least as early as myogenin upregulation (Day 1) and before MHC upregulation
(Day 2) as all myogenin positive cells exhibited reorganized nuclear speckles as well as
some MHC negative myoblasts (Figure 4.1 and Figure 4.2). Nuclear speckle
reorganization also occurs independently of multinucleation (Figure 4.1 and Figure 4.2).
Nuclear speckle reorganization is slightly less distinct than nucleolar reorganization.
Furthermore, given that the brightness of the immunofluorescence signal is one
characteristic used to identify reorganized nuclei, it is important to find some way of
standardizing and quantifying this reorganization. One way to do this would be to
measure multiple nuclear speckles in both myoblasts and myobubes and set a threshold
measurement to distinguish the reorganized nuclear speckle pattern from the nuclear
speckle pattern in undifferentiated nuclei.
Nucleoli also underwent reorganization during differentiation of C2C12
myoblasts. It was observed that myoblasts consistently possessed approximately 5-10
nucleoli per nuclei and myotubes possessed approximately 1-5 nucleoli per nuclei, a
131

trend that when graphed created a characteristic shift in peaks between myoblasts and
myotubes (Figure 4.11). GM was added back to differentiated myoblasts at Day 4 and
nucleoli counts were repeated at Day 8 and the shift in peaks was still present indicating
that nucleolar reorganization is not irreversible. Nucleoli reorganized between
approximately Day 1 and Day 2 (Figure 4.3 and Figure 4.4). At Day 0, spontaneously
differentiating myoblasts which were positive for myogenin did not exhibit the
reorganized nucleolar phenotype (Figure 4.3, Panels A-D) but all MHC positive
myoblasts did (Figure 4.4) indicating that nucleolar phenotype may take place soon after
myogenin upregulation but before MHC expression. To further examine nucleolar
reorganization, I optimized conditions for live cell imaging of differentiating C2C12 cells.
To our knowledge live cell imaging of C2C12 cells had never been published. In order to
film nucleolar reorganization in differentiating C2C12 cells I had to first optimize
transfection of CFP-fibrillarin. Once I had optimized transfection of CFP-fibrillarin, I then
performed time course experiments in which I fixed transfected cells every eight hours in
order to determine a optimal window of time during which nucleoli reorganize.
Untransfected cells were fixed congruently with the transfected cells and labeled for
endogenouse fibrillarin to confirm that endogenous and exogenous fibrillarin localized
and reorganized in the same manner. Finally, because the transfection of CFP-fibrillarin
was transient, I performed experiment to determine the earliest point at which the CFPfibrillarin was detectable so that I could begin the differentiation time course as soon as
possible. After numerous attempts, I obtained a video which suggests that nucleolar
fusion is the method of reorganization for nucleoli. Many more data sets must be
obtained and quantified before we can confidently conclude that nucleolar fusion is the
method of nucleolar reorganization.
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In order to assert that the observed nuclear reorganization was not an artifact of
experimental manipulation performed to induce differentiation, specifically, serum
starvation, I performed a serum starvation test on additional cells lines which do not
undergo differentiation. MEF cells were chosen because they do not undergo
differentiation and MEFs are a mouse cell line. HeLa cells were also used for the serum
starvation test. By using MEF and HeLa cells, I was able to rule out that nuclear
reorganization was simply an artifact of serum starvation and that the nuclear
reorganization observed was a mouse-specific phenomenon. For each day to the serum
starvation test, MEF and HeLa cells maintained in high serum conditions (DMEM + 10%
FBS) as well as low serum conditions (DMEM + 0.05% FBS) were fixed in formaldehyde
and immunolabled for nuclear speckle protein Son and nucleolar protein fibrillarin
(Figures 4.5, 4.6, 4.8, and 4.9). The number of nucleoli per nuclei of both HeLa (Figure
4.7) and MEF (Figure 4.10) cells were scored to see if the number of nucleoli per nuclei
would change as observed in C2C12 nucleoli counts of myoblasts and myotubes (Figure
4.11). A change in the average number of nucleoli per nuclei between high serum and
low serum was not observed for either HeLa or MEF cells which again indicated that
nuclear reorganization is neither mouse specific or a result of serum starvation. On Day
2, MEF cells exhibited a slight change in the average number of nucleoli per nuclei, MEF
cells maintained in low showed an average of three nucleoli per nuclei and MEF cells
maintained in high concentrations showed an average of four nucleoli per nuclei (Figure
4.10). However, the shift in average number of nucleoli per nuclei was very slight in
comparison to the shift of peaks which were observed in C212 counts in which
myoblasts (cells negative for muscle specific proteins myogenin and MHC) showed an
average of six to nine nucleoli per nuclei and myotubes (cells positive for muscle specific
proteins myogenin or MHC) showed an average of three nucleoli per nuclei. Mitotic cells
were also scored for HeLa, MEF, and C2C12 cells to assert that the HeLa and MEF cells
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were reacting to serum starvation as expected. Both MEF cells maintained in low serum
conditions and C2C12 cells showed a significant decrease in mtitoc cells between Day 1
and Day 4 of the time course, which was expected. HeLa cells maintained in low serum
conditions actually showed an overall 2% increase in mitotic cells and ended with a 4%
mitotic population on Day 4; however, in comparison to all cells maintained in high
serum conditions the HeLa cells maintained in low serum conditions still had a much
lower proportion of mitotic cells within the population (Table 4.1).
In addition to experiments using HeLa and MEF cell lines, an experiment was
done with C2C12 cells in which differentiation was induced without serum starvation. In
this experiment the C2C12 cells were plated at a higher density than normal to allow for
increased cell-to cell contact resulting in spontaneous differentiation. Throughout this
differentiation time course the growth medium (GM) was replenished every 48 hours to
ensure the absence of serum starvation. The cells that were induced to differentiate
through cell-to cell contact in the absence of serum starvation exhibited reorganization of
both nuclear speckles and nucleoli identical to the nuclear reorganization observed in a
normal time course. This data, together with the HeLa and MEF serum starvation
experiments, suggests that the nuclear reorganization observed in differentiating C2C12
cells is not mouse specific nor a result of serum starvation but a result of the
differentiation process. This experiment could have also been done by plating the cells
at the normal density and inducing differentiation chemically with paraquat, which has
been previously shown to induce differentiation in C2C12 cells (Okabe et al., 2009).
Overexpressing the inhibitor of differentiation (Id) protein in order to prevent
differentiation in the presence of serum starvation in C2C12 cells would also assert
whether or not the observed nuclear reorganization is a result of serum starvation.
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Finally, depleting MyoD and serum starving C2C12 cells could also be used to assert or
deny that nuclear reorganization is a result of nuclear reoganziation.
Given that nuclear speckles posses numerous pre-mRNA processing factors and
gene expression is greatly altered in order in order to induce differentiation, I believe that
reorganization of nuclear speckles is a result of shifts in gene expression which occur
during differentiation and nucleoli appear larger and more prominent in differentiated
cells. The number of nucleoli present in C2C12 nuclei is reduced during differentiation.
Studies have shown that proliferating cells have a much higher number of nucleoli in
comparison to primary cells which are not in a proliferative state (Terekov, et al., 1984).
In order to differentiate, myoblasts must first stop dividing and exit the cell cycle;
therefore, the decrease in number of nucleoli per nuclei observed in differentiating
myoblasts may be a result of the shift away from a proliferative state which occurs during
differentiation.
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